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Tissue engineering aims to regenerate or create damaged or lost organs and tissues by 
utilizing biodegradable scaffolds, cells and growth factors. One promising tissue engi-
neering strategy involves seeding cells into a porous scaffold and culturing it in vitro, 
which is followed by implantation into the defect site. Cell seeding should result in a 
uniform distribution of cells inside the scaffold - otherwise the functionality and mechan-
ical properties of the engineered construct can be compromised. Also a high seeding ef-
ficiency is appreciated to avoid wasting valuable cells and to enable faster tissue for-
mation. 
The aim of this study was to test six different cell seeding methods in order to find an 
optimal method for supercritical carbon dioxide (ScCO2) processed scaffolds. Of these 
scaffolds, one was a copolymeric poly(L-lactide-co-ε-caprolactone) 70/30 (PLCL) scaf-
fold, whereas the other one was a composite of PLCL and β-tricalcium phosphate. The 
functionality of the cell seeding methods was verified with two scaffold types that were 
manufactured from poly-L/D-lactide 96L/4D (PLDLA 96/4) fibers. In addition, a novel 
cell seeding model utilizing iron-labeled microspheres with diameters of 15 µm and 
100 µm was proposed. Adipose-derived stem cells (ASC) were used in the experiments 
due to their potential in hard-tissue engineering. 
The study revealed that the microsphere seeding model is functional, offering useful in-
formation about the seedability of the ScCO2 processed scaffolds. The microsphere dis-
tributions were noticed to be more uniform compared to the corresponding cell seeding 
results. The microsphere model also suggested more challenging seedability of the com-
posite scaffolds compared to the PLCL substrates. Applying micro-computed tomogra-
phy (micro-CT) imaging and seeding ASCs fed with iron oxide nanoparticles, it was 
noted that the uniformity of the cell distribution in ScCO2 processed PLCL scaffolds can 
be enhanced by forcing the cell suspension into the scaffold with a syringe.  
Due to technological limitations, evaluating cell seeding in the composite scaffolds was 
more challenging. However, the cell experiments supported the microsphere model, indi-
cating a more difficult seedability compared to the PLCL scaffolds. A static pipetting of 
cells on top of the PLDLA fabrics was enough to provide desirable cell distribution and 
cell numbers in those scaffold types. 
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Kudosteknologia pyrkii korjaamaan tai luomaan uusia kudoksia ja elimiä vaurioituneiden 
tilalle. Se hyödyntää biohajoavia tukirakenteita (skaffoldeja), soluja ja kasvutekijöitä yk-
sinään tai yhdessä. Eräs lupaava kudosteknologian menetelmä alkaa solunsyötöllä, jossa 
huokoiseen skaffoldiin istutetaan soluja ja rakennetta kasvatetaan in vitro ennen sen im-
plantoimista vaurioalueelle. Solunsyötön pitäisi johtaa tasaiseen solujakaumaan skaffol-
din sisällä - muuten rakennetun kudoksen toiminnollisuus ja mekaaniset ominaisuudet 
saattavat jäädä odotettua huonommiksi. Jotta arvokkaita soluja ei hukattaisi, solunsyöttö-
prosessin tulisi olla myös tehokas. Tämä edesauttaa myös nopeampaa kudoksen muodos-
tumista. 
Työssä testattiin kuutta erilaista solunsyöttömenetelmää tarkoituksena optimoida syöttö-
menetelmä kahdelle ylikriittisellä hiilidioksidilla prosessoidulle skaffoldityypille. Näistä 
toinen oli poly(L-laktidi-ko-ε-kaprolaktoni) 70/30 (PLCL) -kopolymeeristä valmistettu ja 
toinen PLCL:n sekä β-trikalsiumfosfaattikeraamin komposiitti. Solunsyöttömenetelmien 
toimivuus varmistettiin kahdella poly-L/D-laktidi 96L/4D (PLDLA 96/4) kuiduista val-
mistetulla skaffoldityypillä. Lisäksi tutkittiin uudenlaista solunsyöttömallia, joka pohjau-
tuu rautaa sisältäviin mikropartikkeleihin. Mallissa soluja jäljiteltiin halkaisijaltaan 
15 µm ja 100 µm kokoisilla partikkeleilla. Aikuisen rasvan kantasoluja käytettiin soluko-
keissa, koska niillä on valtava potentiaali ruston ja luun kudosteknologiassa.  
Tutkimuksissa mikropartikkelisolunsyöttömallin huomattiin toimivan ja tarjoavan hyö-
dyllistä tietoa skaffoldien rakenteesta ja sen soveltuvuudesta solujen istutukseen. Rauta-
partikkelien jakaumat vaikuttivat tosin tasaisemmilta kuin vastaavien solunsyöttökokei-
den tulokset. Solunsyöttömalli osoitti myös komposiittiskaffoldien rakenteen olevan so-
lunsyötön suhteen haasteellisempi kuin vastaavien PLCL skaffoldien. Mikro-CT kerros-
kuvauksen avulla pystyttiin havaitsemaan myös nanokokoluokan rautaoksidipartikke-
leilla leimattujen solujen sijainti skaffoldien sisällä. Tämän perusteella huomattiin, että 
tavallisella ruiskulla voitiin pakottaa solususpensiota PLCL skaffoldien sisään ja parantaa 
siten solujen tasaista jakautumista verrattuna muihin menetelmiin.  
Johtuen teknologisista rajoitteista solunsyötön onnistumisen arviointi komposiittiskaffol-
deissa oli haasteellista. Solunsyöttöä rautapartikkeleilla mallinnettaessa huomattiin nii-
den rakenteen olevan kuitenkin hieman vaikeampi solujen istutusta ajatellen. Perinteinen 
staattinen solujen pipetointi skaffoldin pinnalle oli riittävä PLDLA kuituskaffoldeissa, 
tuottaen tasaisen solujakauman ja tyydyttävän solumäärän skaffoldeissa. 
iii 
PREFACE 
This study was performed as a collaboration between the Biomaterials Science and Tis-
sue Engineering Group of Tampere University of Technology and the Adult Stem Cell 
Group of the Institute of Biosciences and Medical Technology (BioMediTech) at the Uni-
versity of Tampere. 
First, I would like to express my deepest gratitude to Professor Minna Kellomäki for of-
fering me this fantastic opportunity and for her professional comments regarding the 
study. I am also very grateful to Docent Susanna Miettinen for providing the facilities for 
this study and for her valuable advices throughout the project. My supervisor Ph.D. 
Kaarlo Paakinaho has counseled and challenged me in a most instructive way, for which 
I am highly thankful. In addition, I would like to thank Ph.D. Kaarlo Paakinaho and M.Sc. 
Laura Johansson for providing materials for this project. 
I am extremely grateful to M.Sc. Sanna Pitkänen for her patient, precise and thorough 
guidance during this work, as well as for her valuable feedback throughout the project. 
Also laboratory technicians Anna-Maija Honkala, Miia Juntunen and Sari Kalliokoski 
have advised me a lot during this work, for which I am very thankful. I owe my gratitude 
to M.Sc. Markus Hannula for sharing his expertise in imaging and data analysis with me 
and for providing the 3D images and scaffold porosity analyses for this work. I also would 
like to thank the rest of my colleagues at BioMediTech for their help during this project. 
Finally, I want to thank my family and friends for their support. Especially, I want to 
thank Maaria for her love. 
 
 
Tampere, 20.05.2015 
 
Aleksi Hänninen 
iv 
TABLE OF CONTENTS 
1. INTRODUCTION .................................................................................................... 1 
2. CELL SEEDING ....................................................................................................... 3 
2.1 The purpose and requirements of successful cell seeding.............................. 3 
2.2 Cell seeding methods ..................................................................................... 5 
2.2.1 Scaffold pre-wetting ......................................................................... 5 
2.2.2 Static cell seeding............................................................................. 5 
2.2.3 Dynamic cell seeding ....................................................................... 6 
2.2.4 Bioreactors ..................................................................................... 10 
3. BIOMATERIALS IN TISSUE ENGINEERING ................................................... 12 
3.1 Natural bone and cartilage............................................................................ 12 
3.2 Scaffold materials ......................................................................................... 14 
3.2.1 Polylactide and its copolymers ...................................................... 14 
3.2.2 β-tricalcium phosphate ................................................................... 16 
3.2.3 Composite biomaterials.................................................................. 17 
3.3 Scaffold fabrication ...................................................................................... 17 
3.3.1 Scaffold design requirements ......................................................... 17 
3.3.2 Supercritical CO2 processing ......................................................... 18 
3.3.3 Polymer fiber processing and textile technologies ........................ 20 
3.4 Scaffold analysis with micro-computed tomography................................... 21 
4. STEM CELLS ......................................................................................................... 23 
4.1 Stem cell sources and development potential .............................................. 23 
4.2 Adipose-derived stem cells .......................................................................... 24 
4.2.1 ASC characteristics ........................................................................ 25 
4.2.2 Characterization ............................................................................. 26 
4.2.3 ASC differentiation into osteogenic lineages ................................. 27 
4.2.4 ASCs in bone tissue engineering ................................................... 28 
5. MATERIALS AND METHODS ............................................................................ 31 
5.1 Scaffold fabrication ...................................................................................... 31 
5.2 A novel cell seeding model with iron-labeled microspheres and micro-CT 32 
5.3 Cell isolation and culture.............................................................................. 33 
5.3.1 Human adipose-derived stem cell isolation ................................... 33 
5.3.2 Characterization of the adipose-derived stem cells ........................ 34 
5.3.3 Cell maintenance and passaging .................................................... 34 
5.3.4 USPIO-labeling of the cells ........................................................... 35 
5.4 Cell seeding methods ................................................................................... 36 
5.4.1 Scaffold pre-wetting ....................................................................... 37 
5.4.2 Static method.................................................................................. 38 
5.4.3 Squeezing method .......................................................................... 38 
5.4.4 Centrifugation method ................................................................... 38 
5.4.5 Injection method ............................................................................ 39 
v 
5.4.6 Syringe 1 method ........................................................................... 39 
5.4.7 Syringe 2 method ........................................................................... 39 
5.4.8 Post cell seeding treatment ............................................................. 40 
5.5 Analyses ....................................................................................................... 40 
5.5.1 Cell viability and distribution in 2D (Live/Dead staining) ............ 40 
5.5.2 Quantitative cell proliferation assay (CyQUANT assay) .............. 41 
5.5.3 3D cell distribution of the USPIO-labelled cells (Micro-CT)........ 42 
5.5.4 Prussian blue staining for iron ....................................................... 42 
6. RESULTS ............................................................................................................... 44 
6.1 Pore interconnectivity analysis with microspheres ...................................... 44 
6.2 Characterization of the hASCs ..................................................................... 46 
6.3 Cell seeding results....................................................................................... 47 
6.3.1 Cell viability and 2D distribution................................................... 47 
6.3.2 Quantitative cell number ................................................................ 51 
6.3.3 Micro-CT & Prussian blue ............................................................. 53 
7. DISCUSSION ......................................................................................................... 58 
7.1 Scaffold properties and microsphere cell seeding model ............................. 58 
7.2 Stem cells and cell culturing ........................................................................ 60 
7.3 Cell seeding methods ................................................................................... 61 
7.4 Cell viability and 2D distribution analysis ................................................... 63 
7.5 Cell number analysis .................................................................................... 65 
7.6 USPIO-labelled cells and the 3D distribution .............................................. 67 
8. CONCLUSIONS ..................................................................................................... 70 
REFERENCES ................................................................................................................ 71 
 
Appendix 1: Well plate images of COMP50 scaffolds           
Appendix 2: Live/Dead experiments 1 & 2             
Appendix 3: PLCL & COMP50 CyQUANT results                      
Appendix 4: PLCL Micro-CT Experiments 1 & 2           
Appendix 5: Prussian blue results 
 
vi 
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°C Celsius degree 
2D  Two-dimensional 
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1. INTRODUCTION 
Severely injured or diseased tissues and organs are often reconstructed using artificial 
tissues or organ transplants. These kinds of alternatives do not always repair the function 
of the lost tissue and there are problems related to immune rejection and limited number 
of donated organs. Described as an ultimately ideal treatment, tissue engineering strives 
for regenerating new organs and tissues without any of the listed problems. (Ikada 2006; 
Chapekar 2000) 
Currently, autografts are the golden standard for bone repair due to their osteoconductive 
and osteoinductive properties and thus dominate the bone grafting business that has sales 
of over 2.5 billion dollars per year. The problems with autografts are related to their lim-
ited availability, donor-site morbidity and cost. Bone tissue engineering as a leading field 
in multidisciplinary tissue engineering can provide a functional biological substitute to 
bone grafts. The most promising strategy in bone tissue engineering involves seeding 
adult stem cells or osteoblasts into a 3D scaffold, culturing the construct in vitro and 
implanting it into the defect site. (Pina et al. 2015; Costa-Pinto et al. 2011; C.M. Murphy 
et al. 2013) 
Adipose-derived stem cells have been considered as a suitable alternative for tissue engi-
neering due to their multilineage differentiation capacity. Regardless of the target tissue, 
large engineered tissue constructs require uniform and efficient cell seeding in order to 
achieve functional tissue equivalents. (Tirkkonen et al. 2012; Vunjak-Novakovic et al. 
1998) In this work, different cell seeding methods were compared with respect to cell 
viability, number and distribution. Four different scaffold types were examined by seed-
ing human adipose-derived stem cells into them, using six cell seeding methods.  
2 
THEORETICAL PART 
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2. CELL SEEDING 
Tissue engineering utilizes three basic components, namely cells, biomaterial templates 
called scaffolds and signals such as growth factors. These three can be applied together 
or individually. (Ikada 2006) One tissue engineering approach involves in vitro genera-
tion of engineered tissue, which generally begins with the attachment of cells on three-
dimensional (3D) scaffolds. This phase is referred to as cell seeding. (Bueno et al. 2007) 
This chapter explains the rationale behind successful cell seeding and presents some of 
the most typical cell seeding parameters and methods that have previously been used. 
2.1 The purpose and requirements of successful cell seeding 
Being the first step of the process, optimal cell seeding is essential in successful cultiva-
tion of large in vitro tissue constructs (Vunjak-Novakovic et al. 1998). The in vitro de-
velopment of engineered tissues is highly enhanced by uniform distribution of the at-
tached cells and an optimal initial cell concentration. The deficiencies in cell seeding are 
generally hard to compensate later during the tissue cultivation period. (Vunjak-
Novakovic & Radisic 2004) 
Uniformly distributed cells enable uniform extracellular matrix (ECM) deposition, which 
leads to uniform tissue growth that affects the functionality of the tissue. High seeding 
efficacy, meaning a high ratio of attached cells to seeded cells is important for rapid tissue 
regeneration. A successful cell seeding process includes also fast cell attachment to scaf-
folds and a high cell survival percentage. Thus, evaluating cell seeding should be done 
by determining cell distribution, the amount of deoxyribonucleic acid (DNA) and viabil-
ity of the cells. (Bueno et al. 2007; Kinner & Spector 2002; Vunjak-Novakovic & 
Radisic 2004) 
After cell seeding, the resulting cell-scaffold construct can be cultivated under applicable 
conditions to enable tissue formation (Vunjak-Novakovic & Radisic 2004). Ultimately, 
the newly engineered tissue could be integrated into functional tissue and the biodegrada-
ble scaffold should be slowly replaced by cell migration, proliferation and ECM produc-
tion (Thevenot et al. 2008). Even though cell seeding has been studied widely using dif-
ferent scaffolds and cell types, the studies are typically narrowed to a specific application 
and thus cannot be generalized to other tissue engineering cases (Bueno et al. 2007). 
In order to permit a higher rate of tissue development, optimal initial construct cellularity 
is appreciated. Also user independence and high reproducibility should be considered. 
Although these requirements apply to most tissue engineering cases, their criticality 
ranges between different types of cells and scaffolds. Hence, the conditions and duration 
of the seeding process need to be cautiously selected. Anchorage-dependent and shear-
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sensitive cells for example should be seeded with a high kinetic rate in order to minimize 
their time in a suspension culture. (Vunjak-Novakovic et al. 1998; Vunjak-Novakovic & 
Radisic 2004; Soletti et al. 2006; Bueno et al. 2007)  
Facilitating fast cell attachment not only enhances the survival of anchorage-dependent 
cells, but also accelerates tissue ingrowth in the scaffolds. On the other hand, many pol-
ymeric scaffolds are typically hydrophobic and possess small pore sizes, for which the 
capillary resistance is larger. In such cases longer seeding times are required - cellular 
penetration can be even completely hindered. In order to fasten the seeding process, ex-
ternal forces can be applied, but it is possible that mechanical forces like shear stress lead 
to shear-mediated membrane lysis or trigger apoptotic pathways. (Bueno et al. 2007; Li 
et al. 2007; Nguyen et al. 2012; Dardik et al. 2005) 
A high cell density, in other words the number of cells per construct or volume unit, can 
be favorable for tissue formation in 3D constructs by affecting cell-cell and cell-scaffold 
interactions. Thereby one of the key parameters in obtaining a decent seeding result is the 
cell seeding density, which can be thought as the number of cells per cubic centimeter 
introduced to the scaffold. The effect of different seeding densities depend on the tissue 
type and the culture conditions. Low seeding densities can prolong the time needed to 
obtain a well-populated scaffold ready for implantation, which can prevent their use in 
bioengineering applications. (Bueno et al. 2007; Shimizu et al. 2007; Grayson et al. 2008; 
Godbey et al. 2004) 
Even though low seeding densities have also been linked to loss of mechanical integrity 
and limited cell proliferation, the properties of the seeded construct cannot automatically 
be increased by increasing the seeding density. For example, in a prior study no improve-
ment in bone formation of tissue engineered bone was seen, although a more homogenous 
cell distribution was reported, when seeding densities of 1 × 106 cells per cm3 and 10 × 106 
cells per cm3 were compared. Moreover, indicating scaffold saturation, the seeding effi-
ciency and the survival of cells seem to decrease when seeding density is increased. An-
yhow, better understanding of the effects of initial cell density is needed. (Bueno et al. 
2007; Holy et al. 2000; Grayson et al. 2008) 
Along with cell seeding density and the seeding method, also cell source contributes con-
siderably to the seeding efficiency (Kinner & Spector 2002). The cells used in tissue en-
gineering have certain general requirements like isolation from a tissue, in vitro prolifer-
ation in order to increase the cell mass for seeding large 3D scaffolds and the capacity to 
differentiate into functional target tissues (Vunjak-Novakovic & Radisic 2004). Fast pro-
liferating stem cells might compensate low scaffold cellularity, but seeding slowly pro-
liferating mature cells like chondrocytes or osteoblasts in an inefficient manner leads to 
catastrophic consequences in terms of tissue development. Obtaining differentiated ma-
ture cells in sufficient numbers for a tissue engineering scaffold is also difficult, but on 
the other hand there are ethical considerations with the stem cells. (Bueno et al. 2007) 
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2.2 Cell seeding methods 
There are many different cell seeding methods and various ways to classify different 
seeding strategies. The methods can be divided into active and passive (Solchaga et al. 
2006), surface and bulk seeding (Soletti et al. 2006) or static and dynamic (Buizer et al. 
2013; Melchels et al. 2010; Zhu et al. 2010) seeding. Here, a view modified from (Burg 
et al. 2000) is used, where three main seeding strategies are distinguished. These are 
static, dynamic (external forces are applied but bioreactors are excluded) and bioreactor 
(such as spinner flask and perfusion systems) seeding.  
2.2.1 Scaffold pre-wetting 
Common to all cell seeding methods is that the scaffolds need to be pre-wetted with cul-
ture medium before the seeding process. The reason lies in displacing air in the scaffold, 
which could prevent the migration of cells and medium to the center of the scaffold.  Pre-
wetting also permits proteins from the culture medium to adsorb to the surface of the 
scaffold. This makes the surface of polymers like poly(ε-caprolactone) (PCL) less hydro-
phobic, which enhances cell attachment. Pre-wetting can be done for example by applying 
vacuum or pressure on scaffolds sunk in culture medium. (Vunjak-Novakovic & Radisic 
2004; Wang et al. 2006; Melchels et al. 2010) 
2.2.2 Static cell seeding 
Static seeding is the most frequently used cell seeding method. It means mixing cell seed-
ing suspension with a scaffold without applying external forces. (Buizer et al. 2013) Two 
common static seeding methods are schematically illustrated in Figure 1. Typically cell 
suspension is spread on top of the scaffold using a pipette. Static cell seeding can be 
applied to every cell type and scaffold structure, although it is thought to be the least 
efficient approach. The scaffold is incubated with the seeded cells from hours to days in 
order to maximize cell seeding efficiency. (Adebiyi et al. 2011; Villalona et al. 2010) 
 
Figure 1. Pipetting and soaking are two common static cell seeding methods. After cell 
seeding, the cell-scaffold constructs can be cultivated in growth medium alone. Modified 
from (Hasegawa et al. 2010). 
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Static seeding relies on gravitational forces alone and requires large pore sizes that allow 
cell penetration throughout the scaffold. Owing its popularity mostly to its simplicity, it 
also does not require costly equipment or expose cells to possibly damaging forces. The 
problems of static seeding include low seeding efficiencies and inhomogeneous spatial 
cell distribution in the scaffold. (Li et al. 2007; Ji et al. 2011; Dai et al. 2009; Buizer et 
al. 2013) Seeding small cell suspension volumes (100 µl) with a large number of cells 
might lead to formation of cell aggregates on the scaffold surface. These aggregates may 
cover the pores and prevent other cells from migrating to the inner parts of the scaffold. 
After the seeding process, the cells in the center of the scaffold might be too far from the 
surfaces and become necrotic due to lack of nutrients or oxygen. An open pore network 
facilitates nutrient and oxygen transport during static culture phase that follows cell seed-
ing. (Ding et al. 2008; Melchels et al. 2010) On the other hand, this might be the case 
with any cell seeding method followed by static culture phase. 
In many cases the penetration of cells depends on the material and porosity of the scaffold 
(Villalona et al. 2010) and there are thus different views about the recommendable appli-
ance of static seeding techniques. According to Vunjak-Novakovic and Radisic, static 
seeding can be successfully used if the scaffolds are thinner than 2 mm (Vunjak-
Novakovic & Radisic 2004). Schliephake et al. claim penetration of cells to a maximum 
depth of 500 µm depending on the material of the scaffold (Schliephake et al. 2009), 
while Zhu et al. recommend static seeding to scaffolds with a thickness less than 1.2 mm 
(Zhu et al. 2010). Dong et al. suggest that the seeding efficiency is always low, even with 
excellent scaffolds containing large pores. The reason presented was the presence of air 
in the pores, which emphasizes the importance of pre-wetting. (Dai et al. 2009) 
The seeding efficiency might increase if the scaffold is flipped at timed intervals like 
every hour. In addition to the static seeding method where the cell suspension is spread 
on top of the scaffold with a pipette, there are other alternatives to seed scaffolds statically 
with cells. For example, the cell suspension can be injected into multiple evenly divided 
points using an injection needle or small cuts can be applied to the scaffold surface using 
a scalpel. Injection seeding is beneficial especially if cell seeding needs to be performed 
in a specific area within the scaffold, but at the same time it damages the scaffold. Another 
static seeding method involves soaking scaffold granules in cell suspension. (Vunjak-
Novakovic & Radisic 2004; Vitacolonna et al. 2013; Thevenot et al. 2008; Buizer et al. 
2013) 
2.2.3 Dynamic cell seeding 
There are numerous articles where spinner flasks, rotating vessel and perfusion bioreac-
tors are described as dynamic cell seeding methods (Burg et al. 2000; Melchels et al. 
2010; Vunjak-Novakovic & Radisic 2004). In this text, bioreactor systems like this are 
excluded from dynamic cell seeding techniques and form their own chapter. The reason 
for this lies in the fact that such bioreactors are often used also for culturing the cells after 
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the seeding process, which can lead to very different seeding results compared to static 
culture. In dynamic seeding an external force is applied to seed cells to the scaffold, which 
distinguishes it from static seeding. (Burg et al. 2000; Buizer et al. 2013) 
The most common strategies of dynamic cell seeding utilize hydrostatic forces as for ex-
ample in centrifugation, or create pressure differentials (Villalona et al. 2010). Further 
examples include methods using electric or magnetic fields as driving forces. Although 
dynamic seeding might yield in more homogenous and efficient seeding results compared 
to static seeding, the methods are more complex and possibly lead to prolonged seeding 
time. In addition, all the dynamic seeding methods have their own specific disadvantages. 
One relatively easy way to improve seeded cell density and uniformity of the cell distri-
bution is to apply mild suction to help the cells to permeate through the scaffold. For 
elastomeric scaffolds like poly(L-lactide-co-ε-caprolactone) (PLCL) sponges, it is possi-
ble to use compression forces to induce suction that has helped rabbit chondrocytes to 
infiltrate to the scaffold. Multiple cycles of compression-induced suction were reported 
to increase the uniformity of the cell distribution, but also to slightly decrease cell viabil-
ity. (Soletti et al. 2006; Buizer et al. 2013; Melchels et al. 2010; Xie et al. 2006) An 
illustration of this method is presented in Figure 2.  
 
Figure 2. Elastomeric scaffolds can be seeded in a dynamic manner by applying com-
pression-induced sectional forces. Modified from (Xie et al. 2006). 
Rotational seeding is a common strategy used for example in vascular tissue engineering. 
In addition to rotational bioreactor systems, dynamic cell seeding method involving cen-
trifugal forces has been investigated. This requires fewer cells and less time in comparison 
to spinner flask bioreactors. As a consequence, cell media and other resources are needed 
in lesser quantities and the time from cell seeding to cell proliferation phase is shorter. 
Although cell viability is generally maintained in centrifugal cell seeding, there are con-
cerns whether cell morphology remains unaffected in the process. With too high rotation 
speeds, also cell lysis has been reported. (Villalona et al. 2010; Godbey et al. 2004) 
Godbey and his colleagues investigated different rotation speeds within the range of 
0-6000 rpm using murine bladder smooth muscle cells or human foreskin fibroblasts and 
polyglycolide (PGA) fiber scaffolds with porosities of 95%. Since the centrifuges used 
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did not allow smooth rotation below 2000 rpm and unbalanced centrifugation resulted in 
unwanted cell shearing, the rotor speed was set constant to 2500 rpm for the experiments. 
In this case, this translates to 35.0 times gravitation (× g) at the inner surface of the scaf-
fold and 52.5 × g at the outer surface. In comparison, spinner flasks typically utilize seed-
ing conditions up to 500 rpm. From different centrifugation times tested, 10 minutes was 
found to be the optimal choice with even better results if the centrifugation time was 
broken into one minute segments. The cellular distribution and seeding efficiency were 
superior compared to static and spinner flask seeding. The method was reported to be 
especially efficient at low cell concentrations (1.33 × 105 cells/ml) and recommended to 
be used for planar and cylindrical scaffolds. (Godbey et al. 2004; Villalona et al. 2010) 
Later, different conditions were tested by spinning PGA fiber mesh sheets and ovine bone 
marrow stromal cells 5 × 2 minutes at 2500 rpm. After each cycle, the unattached cells 
were re-suspended. Again, improved seeding efficiency and cell distribution were re-
ported. (Roh et al. 2007) Seeding fibroblasts on 0.7 mm thick porous fibrin scaffolds by 
centrifuging them for 5 minutes at 1000 rpm was investigated by Lam et al. in 2007. The 
centrifuge method was found to be superior compared to an orbital shaker method, where 
the cell-scaffold constructs were placed on a shaker for 4 hours at 60 rpm. Nevertheless, 
neither of these methods nor the combined centrifuge and orbital shaker method was able 
to deliver cells deeply into the scaffold. (Lam et al. 2007) 
Seeding techniques applying pressure differentials have been investigated in vascular tis-
sue engineering for decades (Villalona et al. 2010). Low pressure or vacuum have com-
monly been used in tissue engineering to remove air from inside the scaffolds (Dai et al. 
2009; Hasegawa et al. 2010; Vunjak-Novakovic & Radisic 2004). Using hydroxyapatite 
scaffolds and rat bone-marrow derived osteoblasts, Dong et al. concluded that this in-
duced cell suspension flow into the pores and thus increased bone tissue formation in rats. 
Their system consisted of a vacuum pump, desiccator and a controller. The low pressure 
method can naturally be integrated into other seeding systems as well. (Dong et al. 2001) 
Two different low pressure methods were tested by Hasegawa et al. for scaffold degassing 
prior to seeding rat bone marrow-derived stem cells into ceramic scaffolds. The actual 
seeding was done by simply soaking the scaffolds into cell suspension. In the other low 
pressure method, the scaffolds in growth medium were first exposed to pressure of 100 
kilopascals (kPa) and soaked then in cell suspension. The second method applied a sy-
ringe for creating the same pressure of 100 kPa by closing the syringe tip, pulling its 
plunger back, vibrating the syringe and letting the air out. This was repeated a couple of 
times, after which the scaffolds were also soaked in cell suspension. This syringe method 
was noticed to result in higher amount of cells in the scaffold than the other low pressure 
system or two static groups, where the scaffolds were either soaked in cell suspension or 
the cells pipetted on top of the scaffolds. (Hasegawa et al. 2010) 
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Syringes have been applied in low pressure cell seeding also directly and not only for 
scaffold degassing. One way is to set the scaffolds into the syringe, draw cell suspension 
and some air into the syringe, after which the syringe is closed with a cap. By pulling the 
plunger back, low pressure is created within the syringe – this step can be repeated a few 
times. Named “a 1-min method for homogenous cell seeding”, the method was noticed 
to result in a homogenous cell distribution with a cell seeding efficiency equivalent to 
that of static seeding. The scaffolds used included both polymeric and ceramic scaf-
folds. (Tan et al. 2012)  
Another syringe method involving a stopcock can be used to create low pressure first and 
then add cell suspension, or bone marrow as done by Yoshii and his colleagues. A sche-
matic illustration of the method is presented in Figure 3. The β-tricalcium phosphate (β-
TCP) scaffolds were transplanted into intramuscular sites of rabbit and bone formation 
was observed at 5 and 10 week time points. Seeding under low pressure led to signifi-
cantly higher amount of newly formed bone compared to seeding under atmospheric pres-
sure. (Yoshii et al. 2009) 
 
Figure 3. An illustration of a cell seeding method applying low pressure in a syringe 
system. Modified from (Yoshii et al. 2009). 
Despite promising results, the effects of the low pressure treatment on cell viability and 
genetic mutations as well as cell differentiation, de-differentiation and function should 
also be followed (Dai et al. 2009). Moreover, not all publications confirm the efficiency 
of low pressure methods on cell seeding. When comparing low (45%) and high (90%) 
porosity tricalcium phosphate scaffolds, Buizer et al. noticed that the seeding outcome 
was more homogenous with static seeding than with vacuum seeding. Although the vac-
uum method resulted in a higher number of seeded cells on the low porosity scaffolds, 
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after 7 days the cell numbers were comparable regardless of the seeding method. (Buizer 
et al. 2013) 
In addition to the more common dynamic cell seeding methods, less frequently used tech-
niques include for example using cells labeled with magnetite nanoparticles and applying 
magnetic forces (Shimizu et al. 2007) and employing surface acoustic waves (Li et al. 
2007). With very highly porous scaffolds, cell seeding can be challenging because the 
cells might end up to the bottom of the culturing plate. Cell seeding efficiencies of more 
than 90% have been achieved by delivering the cells inside a hydrogel where they are 
entrapped. Despite the possible advantages in dynamic cell seeding methods, these con-
ditions do not ensure a uniform cell distribution. (Hong et al. 2014; Andersen et al. 2013; 
Bueno et al. 2007) 
2.2.4 Bioreactors 
Not only the cell seeding method, but also the following cell proliferation environment 
has been shown to have an effect on the seeding outcome. Bioreactors can be used for 
both dynamic seeding and culturing of the cells. Culturing cells in bioreactors reduces 
problems with mass-transfer limitations. In addition, the behavior and biochemical activ-
ity of the seeded cells can be modified by altering the culturing technique. Seeding scaf-
folds in a bioreactor offers often an automated and controlled process with an effective 
and reproducible outcome. Different bioreactor types include for instance spinner flask, 
rotating wall and perfused chamber bioreactors, which are presented in Figure 4. (Burg 
et al. 2000; Martin & Vermette 2005; Schliephake et al. 2009; Zhu et al. 2010; Martin et 
al. 2004)  
 
Figure 4. Three common bioreactor types: a) spinner flask, b) rotating wall and c) per-
fusion chamber. The scaffolds are shown in white. Modified from (Martin et al. 2004). 
Rotational systems like spinner flask (or stirred-flask) bioreactors are a well-accepted and 
commonly used cell seeding method. In such a system the scaffold is attached to a needle 
that is placed into a spinner flask with cell suspension. A spinner in the flask rotates the 
medium, which drives the cells into the scaffold. The following culture period in the flask 
ranges generally from 12 to 72 hours. With low-speed rotation, spinner flasks have not 
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indicated to affect cell morphology. Since the method requires seeding times of approxi-
mately 24 hours, its practicality is limited especially in applications where the seeded 
scaffold should be implanted the same day. (Godbey et al. 2004; Villalona et al. 2010) 
Perfusion bioreactors are used to prevent diffusional limitations in mass transfer. Perfus-
ing scaffolds with culture medium allows the transport of oxygen to the cells through both 
diffusion and convection. (Vunjak-Novakovic & Radisic 2004) Both cell seeding and the 
subsequent cultivation phases can be performed using a perfusion bioreactor. These kinds 
of bioreactors have been originally designed for vascular grafts, but are used also for 
example in cartilage and cardiac tissue engineering. The medium flow rate can affect the 
results of direct perfusion. (Martin & Vermette 2005) Also the prolonged culture period 
required with perfusion bioreactors leads to a growing risk of fungal and bacterial con-
tamination. Also the complexity of such bioreactors reduce their suitability for clinical 
applications. (Villalona et al. 2010)   
The rotating wall bioreactors comprise of a stationary inner cylinder providing for gas 
exchange and a rotating outer cylinder. In some applications also the inner cylinder can 
be rotated independently from the outer cylinder. The space between these two cylinders 
is filled with culture medium and the scaffolds are placed there after they are seeded with 
cells. Rotating-wall vessels are used for dynamic culturing with low shear stress and high 
mass-transfer rates. In some cases rotating wall bioreactors have shown effectiveness, but 
problems arise for example from random collisions of scaffolds between themselves and 
the culture chamber. Rotating wall bioreactors have been shown to promote osteogenic 
differentiation. Even so, the positive effect of perfusion systems on osteogenic differen-
tiation has been shown to be greater than that of the rotating wall bioreactors. (Yeatts & 
Fisher 2011; Martin & Vermette 2005; Zhang et al. 2010) 
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3. BIOMATERIALS IN TISSUE ENGINEERING 
Reconstructing tissues or organs by a simple cell injection is possible only in few cases. 
In order to form tissues with distinct three-dimensional shapes, support is usually needed. 
Biomaterial scaffolds provide this support by functioning similarly to natural ECM and 
thus promoting cell proliferation and differentiation. (Ikada 2006) When it comes to scaf-
folds, there are two main strategies in tissue engineering. The first approach involves 
using scaffolds as supporting constructs upon which cells are seeded in vitro. Secondly, 
they can be used as devices for growth factor/drug delivery. These two strategies can also 
be combined. The scaffold should degrade over a period of time that would allow tissue 
formation concurrently – ideally the scaffold disappears leaving behind regenerated tis-
sue. (Howard et al. 2008; C.M. Murphy et al. 2013) 
3.1 Natural bone and cartilage 
Bone has a high regeneration potential, for which it is the most investigated tissue in 
tissue engineering. It is also a core theme when it comes to biomaterials in this work. The 
hierarchical structure of bone is so complex that it is still not very well understood. Nev-
ertheless, in order to choose the right biomaterials for bone tissue engineering, it is essen-
tial to understand the composition and properties of bone. The role of this dynamic tissue 
is to function as mechanical support, which provides mineral homeostasis at the same 
time. (Pina et al. 2015; Reznikov et al. 2014; Jang et al. 2009; Costa-Pinto et al. 2011) 
Bone is a family of hierarchically organized complex materials with a network of inter-
connected cells. The four main components of bone include the mineral phase (consisting 
of carbonated hydroxyapatite crystals), collagen (with type I being the most abundant 
protein), non-collagenous macromolecules (such as osteocalcin and osteonectin) and wa-
ter. In bone, these components are arranged in a hierarchical way that can be divided into 
multiple different levels. An elementary unit of bone is the mineralized collagen fibril, 
which, together with water and non-collagenous proteins is responsible for the mechani-
cal properties of bone. The organic matrix constitutes 35% of the mineralized bone ECM. 
The remaining 65% is composed of the mineral matrix. (Reznikov et al. 2014; Costa-
Pinto et al. 2011) 
As seen in Figure 5, bone constitutes of an outer layer called compact or cortical bone 
and an inner layer, which is referred to as spongy or cancellous bone (Nguyen et al. 2012; 
Bose et al. 2012). Both of these layers are highly vascularized, although the compact bone 
is much denser with a porosity of 10-30%. The highly porous spongy bone typically has 
porosities between 30-90%. Correspondingly, the mechanical properties of spongy and 
compact bone vary as well: Young’s modulus of spongy bone ranges between 0.1 and 
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2 GPa whereas that of compact bone lies in the range of 15 and 20 GPa. High vasculature 
within the compact bone is enabled by functional units called osteons. These osteons con-
tain central haversian canals, inside which blood vessels and nerves are located. At the 
same time, spongy bone is porous enough to allow vascularization without osteons. A 
connective, also highly vascularized connective tissue called the periosteum covers the 
surface of most bones. (Bose et al. 2012; Nguyen et al. 2012)  
 
Figure 5. Anatomy of the bone tissue in a nutshell. Modified from (Nguyen et al. 2012).  
The different cell types related to bone maintenance include osteocytes that are terminally 
differentiated and entrapped in the bone ECM, mesenchymal stem cells found in the bone 
marrow, bone-lining cells covering all bone surfaces, osteoblasts that are able to synthe-
size organic non-mineralized bone matrix, and finally osteoclasts being capable of resorb-
ing bone tissue which is the first step of bone remodeling. As a living tissue, most of the 
bone fractures and other defects can be healed through spontaneous regeneration. Defects 
beyond a critical size cannot heal this way. (Costa-Pinto et al. 2011; Puppi et al. 2010; 
Fernandez-yague et al. 2014) 
In synovial joints that connect two bones with each other allowing movement, the bone 
ends are covered by a cushioning cartilage layer. In addition, a capsule in the joint with 
lubricating synovial fluid protects the bone ends. The state when the cartilage layer in the 
bone ends has been worn away is called osteoarthritis. (Starr & McMillan 2015) Mechan-
ical stimulation is part of the development and maintenance of natural cartilage, which 
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should be noticed in tissue engineering as well. Cartilage is an avascular tissue with highly 
differentiated chondrocyte cells present at low concentrations in the ECM. The chondro-
cytes are supplied with nutrients only by diffusion and fluid flow caused by joint loading. 
The cartilage has thus poor self-healing capacity, so even a small cartilage defect can 
result in progressive damage and joint instability. (Jung et al. 2008; Vunjak-Novakovic 
& Radisic 2004; Ohyabu et al. 2010) 
3.2 Scaffold materials 
In tissue engineering, the three typically used biomaterial groups are synthetic polymers, 
natural polymers and ceramics. Due to the design flexibility of synthetic polymers and 
the structural similarity of ceramics with the mineral phase of bone, these two biomaterial 
groups are in focus in this work. (O’Brien 2011; Vergroesen et al. 2011) Especially pol-
ylactide (PLA) and its copolymers like poly(L-lactide-co-caprolactone) (PLCL) are dis-
cussed from the group of synthetic polymers. Most of the attention in the group of ceram-
ics is paid on β-tricalcium phosphate (β-TCP). 
3.2.1 Polylactide and its copolymers 
Polylactides are thermoplastic polyesters from the family of poly-α-hydroxy acids, which 
is the most widely used polymer group in clinical surgeries. Lactide monomers, which 
are dimers of lactic acid, form the polymer backbone of polylactides. They can be pol-
ymerized via direct polycondensation of lactic acid monomers or by ring-opening 
polymerization of lactide. The ring-opening of lactide (presented in Figure 6) is a better 
route for achieving high molecular weight PLA. Since lactic acid exists as two different 
enantiomers, L- and D-lactic acid, PLA refers to a group of polymers depending on the 
form of lactic acid units used to produce lactide dimers and PLA polymers. Of the two 
enantiomers, L-lactic acid exists in the metabolism of animals and microorganisms. 
Therefore, this degradation product of PLA is non-toxic. (Paakinaho et al. 2009; 
Tirkkonen et al. 2012; Huttunen 2013; Lasprilla et al. 2012; Kricheldorf 2001) 
 
Figure 6. A schematic illustration of PLA synthesis by ring-opening polymerization of 
lactide. Starting from the lactic acid monomers (available in L- and D-form), their lactide 
dimers (with possible forms L-, D- and L/D lactide) are polymerized into PLA. Modified 
from (Paakinaho 2013).  
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Especially poly-L-lactide (PLLA) and poly-L/D-lactide (PLDLA) are widely studied in 
the biomedical field due to their biocompatibility and adjustable mechanical and degra-
dation properties (Fonseca et al. 2014; Lasprilla et al. 2012; Ashammakhi et al. 2001). 
These two have different properties: PLLA is crystalline but PLDLA with a smaller L/D 
ratio than 87.5/12.5 is amorphous and has thus weaker mechanical properties. The glass 
transition temperature (Tg) of PLLA is between 60-65°C and melting temperature (Tm) 
175°C and it degrades slower than a 50L/50D PLDLA that has a Tg in a lower range from 
50°C to 60°C. (Fonseca et al. 2014; Vert et al. 1981; Nair & Laurencin 2007; 
Paakinaho 2013) 
Polylactides degrade mainly by hydrolytic degradation, where the ester bonds in the pol-
ymer backbone are cut in a reaction with water. Due to the methyl groups in the polymer 
backbone, high molecular weight polylactide-based materials are hydrophobic. Still, in 
an aqueous environment water can diffuse into the polymer matrix in small quantities 
leading to bulk erosion of the polymer. Following hydrolysis, the molecular weight de-
cays immediately. After reaching a certain molecular weight threshold region, a rapid loss 
of the mechanical properties takes place. In addition to the chemical structure of the pol-
ymer and its water permeability, the degradation rate depends on many factors, such as 
the sterilization method, sample size and the degradation environment. (Huttunen & 
Kellomäki 2013; Ashammakhi et al. 2001; Paakinaho 2013) 
Different polylactide types have been successfully applied in many different clinical ap-
plications, including resorbable sutures and wound dressings (Kricheldorf 2001), small 
joint reconstructions (Honkanen et al. 2010; Ellä et al. 2011) as well as internal bone 
fixation devices like plates and screws (Rokkanen et al. 2000). In tissue engineering, they 
have been considered as drug delivery devices (Nair & Laurencin 2007), non-woven scaf-
fold source materials (Ellä et al. 2007) and other porous 3D scaffolds for reconstruction 
of ligaments, tendon, bone, muscle and cardiovascular tissues (Coutu et al. 2009; 
Lasprilla et al. 2012; Van Alst et al. 2009). The limitations of PLA in tissue engineering 
are related to its acidic degradation products and the lack of reactive side chains for at-
tachment of peptides and other biological cues (Coutu et al. 2009).  
Besides their rare properties that are suitable for bone fixation devices, polylactides owe 
part of their popularity to their processability. For tissue engineering purposes, many dif-
ferent kinds of porous PLA scaffold structures can be produced. The mechanical proper-
ties of PLA can also be adjusted via different processing methods, as in the case of draw-
ing fibers which leads to molecular orientation and higher strength in this direction. Melt 
processing methods are often used in manufacturing of bioabsorbable biomedical devices, 
but the sensitivity of biodegradable polymers to thermal degradation might lead to vary-
ing polymer molecular weights, and thus into variation in the degradation rates. 
(Rokkanen et al. 2000; Ellä et al. 2007; Lasprilla et al. 2012; Ashammakhi et al. 2001; 
Paakinaho et al. 2011) 
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Copolymerization is another efficient way to tailor mechanical, thermal and degradation 
properties of polylactides and other polymers (Paakinaho 2013). Especially the structures 
of the comonomers as well as their molar ratio and sequences have an effect on the co-
polymer properties. Not only are different types of lactide monomers copolymerized with 
each other to achieve PLDLA, they are also copolymerized with other monomer types, 
most typically glycolide and ε-caprolactone. For drug delivery applications, incorporating 
glycolide into the copolylactides is often desirable due to its enhancing effect on hydro-
lytic degradation. Correspondingly, copolymerizing lactides with ε-caprolactone results 
in a decreased degradation rate compared to PLLA and PLDLA polymers. The poly-ε-
caprolactone (PCL) resulting from the ring-opening polymerization of ε-caprolactone is 
highly processable due to its low Tg (-60°C) and Tm (55-60°C) and solubility to a number 
of organic solvents. PCL has an excellent biocompatibility and a high elongation at break-
age (>700%), but its low strength properties require enhancement by copolymerization 
or blending. (Nair & Laurencin 2007; Ellä et al. 2007; Kricheldorf 2001; Lasprilla et al. 
2012) 
PLLA and PCL are both biocompatible and biodegradable polymers, but their degrada-
tion rates and mechanical properties are totally different. Copolymers of lactide and ε-ca-
prolactone combine the properties of the respective homopolymers in a way that leads to 
a material showing elasticity, good drug-releasing properties and processability resulting 
from the ε-caprolactone monomer, as well as improved mechanical properties and faster 
degradation rate compared to PCL homopolymer. (Ahola et al. 2012; Larrañaga et al. 
2014) These properties can be tailored by changing the monomer ratio - thus it must be 
taken into account when comparing the results of different studies. In tissue engineering, 
PLCL has been widely used in different applications such as drug delivery vehicles, scaf-
folds for cartilage reconstruction or cell culturing substrates for endothelial and smooth 
muscle cell culturing. However, especially in bone tissue engineering, the lack of bioac-
tivity in polyesters such as PLCL has led to adding bioactive ceramic fillers into the pol-
ymer matrix to form composites with enhanced properties. (Puppi et al. 2010; Jung et al. 
2008; Xie et al. 2006; Ahola et al. 2012; Larrañaga et al. 2014) 
3.2.2 β-tricalcium phosphate 
Ceramics are crystalline, non-metallic compounds that are typically stiff and brittle with 
a slow degradation rate. Due to their chemical similarity with the inorganic part of natural 
bone, calcium phosphates such as hydroxyapatite (HA) and beta-tricalcium phosphate (β-
TCP) are among the most investigated bone tissue engineering scaffold materials. Both 
HA and β-TCP can be synthetically produced and are highly biocompatible osteoconduc-
tive materials without toxic or immunogenic side effects. However, HA might remain in 
the regenerated bone, whereas β-TCP is completely resorbable. (C.M. Murphy et al. 2013; 
Bose et al. 2012; Pina et al. 2015; Kolk et al. 2012) 
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Having the same calcium/phosphate ratio than the inorganic amorphous phase of natural 
bone, β-TCP is used as granules and blocks to substitute bone grafts. During their degra-
dation, β-TCP and other calcium phosphate ceramics release calcium and phosphate ions 
that can used as raw materials for new bone formation. These ions can also induce bone 
cell activity and induce similar biological responses that are generated in bone remodel-
ing. By forming a strong interface between host bone tissue via direct bonds, calcium 
phosphates stimulate osteoblastic new bone formation and osteoclastic bone resorption. 
Still, their mechanical properties are not sufficient enough for load-bearing applications. 
(Ahola et al. 2012; C.M. Murphy et al. 2013; Kolk et al. 2012; Pina et al. 2015) 
3.2.3 Composite biomaterials 
Composites of calcium phosphate ceramics and polymers combine the advantages of 
these two material classes, including mechanical integrity and bioactivity of calcium 
phosphates as well as toughness, compressive strength and processability of polymers. At 
the same time, it needs to be noted that bioactive ceramic fillers might have an accelerat-
ing or hindering effect on the degradation rate. This kind of composites has been in focus 
especially in bone tissue engineering. When it comes to osteogenesis, 60 weight-% of β-
TCP in PLLA is said to have the same activity than pure β-TCP. (Ahola et al. 2012; Bose 
et al. 2012; Kolk et al. 2012; Huttunen & Kellomäki 2013; Larrañaga et al. 2014; Aunoble 
et al. 2006) 
3.3 Scaffold fabrication 
Not only selecting the appropriate biomaterial, but also selecting a suitable and reproduc-
ible processing method is important in optimizing the scaffolds for each application 
(Vunjak-Novakovic & Radisic 2004; Nguyen et al. 2012). Biodegradable polymers can 
be processed into similar shapes than any other thermoplastics, but the hydrolytic sensi-
tivity of the polymer bonds needs to be taken into account. In practice, the presence of 
moisture needs to be minimized to avoid degradation during processing. Otherwise the 
final polymer properties and molecular weight can be altered. Common processing meth-
ods include extrusion, compression molding, solvent casting and injection molding. 
(Middleton & Tipton 2000) This work focuses on supercritical carbon dioxide (ScCO2) 
processing and technologies related to polymer fibers. 
3.3.1 Scaffold design requirements 
Along with the general requirements like providing temporary mechanical support with 
mechanical properties comparable to host tissue, producing non-toxic degradation prod-
ucts while degrading in a controlled manner and not generating a chronic inflammatory 
response, a crucial feature for a scaffold is interconnected porosity (Bose et al. 2012; 
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Romagnoli et al. 2013). As a highly vascularized tissue, bone regeneration should be bet-
ter when scaffolds enabling greater mass transport are used. The pores are thus essential 
in bone tissue engineering since they allow bone in-growth and vascularization. Porous 
scaffold structure also allows the diffusion of nutrients and oxygen to the cells. Moreover, 
the pores should be interconnected to enable cellular infiltration and growth as well as 
matrix deposition. (Mitsak et al. 2011; Romagnoli et al. 2013; Bose et al. 2012; 
C.M. Murphy et al. 2013; Romagnoli & Brandi 2014) 
Despite its vitality, porosity of the scaffold has also a downward effect on compressive 
strength and other mechanical properties, which leads to a trade-off situation 
(Karageorgiou & Kaplan 2005; Costa-Pinto et al. 2011; Mitsak et al. 2011; Bose et al. 
2012). When it comes to pore sizes, too large pores limit scaffold surface area and thus 
cell adhesion, but on the other hand small enough pore sizes hinder cell migration. This 
can lead to formation of cellular aggregations around the periphery of the scaffold, inhib-
iting nutrient diffusion and waste removal. The hypoxic conditions tend to result in an 
osteochondral process before osteogenesis. Another concern in this kind of a case is prem-
ature core degradation of the construct. The optimal pore size in bone tissue engineering 
is still controversial and pore sizes ranging all the way from 20 to 1500 µm have been 
used. Not only the application, but also the chosen biomaterial has an influence on the 
optimal pore size. (C.M. Murphy et al. 2013; Costa-Pinto et al. 2011; 
Loh & Choong 2013) 
3.3.2 Supercritical CO2 processing 
Many processing methods used to produce tissue engineering scaffolds require the use of 
organic solvents such as dichloromethane. The removal process can be difficult and toxic 
residues can be left behind. Supercritical CO2 processing is a method avoiding the use of 
organic solvents. As a non-toxic, non-flammable, readily available and inexpensive sol-
vent with a tunable density, ScCO2 is an attractive solvent. Under mild conditions, CO2 
is a poor solvent for most high molecular weight polymers, but at high pressures CO2 has 
a solvating power comparable to typical organic solvents. (Howard et al. 2008; Floren et 
al. 2011; Davies et al. 2008; Barry et al. 2006) 
Once the critical temperature (31.1ºC) and pressure (73.8 bar) of CO2 are exceeded, a 
single fluid phase called supercritical CO2 with properties of both liquid and gas is 
formed. In such case, the liquid and gaseous components are identical and further com-
pression will not result in condensation to a liquid state. Instead, only increase in fluid 
density is seen along compression. The liquid-like density as well as the gas-like viscosity 
and compressibility of supercritical fluids allow tuning of the fluid properties by changing 
temperature and pressure. The properties of conventional organic solvents are much less 
dependent on temperature and pressure. (Barry et al. 2006; Quirk et al. 2004; Bhamidipati 
et al. 2013) 
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Processing polymers with ScCO2 is based on its solubility to polymers, which causes 
some polymers to create porous materials by swelling or foaming. At high pressures, pol-
ymers saturated with CO2 plasticize. This plasticization results from the diffusion of 
ScCO2 into the polymer matrix: as the polymer chains are separated, also their chain ro-
tation becomes easier. Plasticization is followed by a decrease in polymer glass transition 
temperature. The stronger the molecular interactions in the polymer, the greater the Tg 
reduction. As the polymer is in this plasticized state and the gas pressure of CO2 is brought 
down to atmospheric pressure, the gas solubility in the polymer decreases, which gener-
ates bubbles (nuclei). The growth of these bubbles result in formation of the pores in the 
polymer. The Tg starts to rise when CO2 leaves the polymer and ultimately reach a tem-
perature near that of the equipment. As the polymer becomes glassy, the pores are locked 
in and cannot grow any further. The process is schematically shown in Figure 7. (Barry 
et al. 2006; Bhamidipati et al. 2013) 
 
Figure 7. Supercritical CO2 processing as a schematic illustration. Modified from (Zhang 
et al. 2014). 
The pore size distribution can be manipulated by tuning the venting rate, which is an 
important parameter along with temperature and pressure. With a high venting rate, the 
nucleation is fast leading to a large number of nucleation sites. The pores develop fast 
and the effect of gas diffusion into the pores becomes insignificant, facilitating uniform 
pore size distribution. Slower venting rate and thus slower nucleation means that the 
firstly nucleated pores become larger than the others. This results from the greater amount 
of gas diffused from the surrounding polymer matrix, shifting the pore size distribution 
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to a more inhomogeneous state. (Barry et al. 2006) One major challenge in CO2 pro-
cessing of polymers has been the problems with pore interconnectivity. This problem can 
be overcome by controlling the processing parameters or using solid porogen particles to 
create an open pore network. (Bhamidipati et al. 2013) 
3.3.3 Polymer fiber processing and textile technologies 
Bioabsorbable polymer fibers have been used as sutures for soft tissue wounds or as re-
inforcing elements in composites, but they also serve as a basis for different types of 
textile structures (Ellä et al. 2011). In addition to non-woven scaffolds, more organized 
scaffold structures can be produced from fibers and yarns by knitting, weaving and braid-
ing technologies. Possible applications of these scaffolds include tendon, cartilage, liga-
ment and bone tissues. (Kellomäki et al. 2015) 
The organized textile scaffolds should be highly porous with an interconnected pore net-
work and a large surface area, although their surface area to volume ratio is still lower 
than that of the non-woven scaffolds. By producing fibers with smaller diameters, the 
surface area to volume ratio of the resulting textiles can be increased. On the other hand, 
handling very thin fibers is more difficult and their mechanical strength is weaker com-
pared to thicker fibers. With rat mesenchymal stem cells, small fiber diameter has been 
also associated with lower cell attachment and spherical-shaped cells due to the big size 
of the cells with respect to the fiber size. (Ellä et al. 2007; Park et al. 2013; Karageorgiou 
& Kaplan 2005) 
The chosen bioabsorbable material should possess adequate thermal and solubility prop-
erties to withstand fiber spinning. Typical methods for this are melt spinning, dry spinning 
and wet spinning, from which the first one is free of harmful solvents but requires a large 
enough temperature window for extrusion. In melt spinning, the material is first melted 
and then extruded into multi- or monofilaments. In order to improve the processability of 
the spun fibers, a stretching phase can be applied to increase their mechanical properties. 
By stretching the fibers above their Tg (but below Tm of semicrystalline materials), the 
polymer chains become oriented in this direction, leading to significant improvement in 
the strength, strain and Young’s modulus of the filaments. PLA and other poly-α-hydroxy 
acids are the most widely used synthetic polymers in melt spinning, but also some natural 
polymers and although rarely alone, even bioactive glasses with a specific chemistry have 
been melt-spun into fibers. (Kellomäki et al. 2015)  
By producing interlocked loops from continuous yarns, a method called knitting can be 
applied to produce fabric scaffolds. Depending on the direction of the series of loops, the 
resulting form is either weft or warp knitted. Weft knitted fabrics can be created from one 
continuous strand of yarn, but they unravel easily which limits their use in applications 
where the end-product is cut into a desired shape. Being more stable and cut-withstand-
ing, the warp knits are more suitable for surgical use. When manufacturing warp knitted 
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products, the number of columns in the width of the fabric determines the number of yarns 
needed in the system: each needle needs its own yarn. The resulting stitching patterns are 
longitudinal with adjacent yarn loops being interlocked with each other. Knitted fabrics 
are easy to shape and elastic. They can be used in tubular or flat form. 
(Kellomäki et al. 2015) 
Knitted structures made from multifilament polylactide 96L/4D fibers have been used for 
both osteoarthritis and rheumatoid arthritis patients. The function of the scaffolds is based 
on inducing fibroblast ingrowth into the structure, which later leads to maturation to con-
nective tissue. As the structure cushions the bone ends, the mobility of the joint is im-
proved. (Kellomäki et al. 2015) Shortly, after the knitting process the resulting knits are 
cut into the desired length depending on the wanted scaffold size. The knits are then rolled 
and the ends are heat sealed to avoid the running of the loop. Finally, the scaffolds are 
heat treated in a mold to achieve the final shape. (Ellä et al. 2011)    
3.4 Scaffold analysis with micro-computed tomography 
The need to evaluate the 3D scaffold structures and the destructive nature of traditional 
histological techniques have led to the development of improved 3D imaging methods. 
In the case of therapeutic applications, the cell-scaffold constructs require both evaluation 
of the scaffold structure and determining the distribution of the cells. When designing 
tissue engineering scaffolds, for example quantifying the pore sizes and interconnectivity 
is essential. In this kind of scaffold research, micro-computed tomography (micro-CT) is 
one widely applied imaging technology. One factor to its popularity is the detailed qual-
itative and quantitative information on sample 3D morphology. The internal structure of 
the scaffolds can be studied accurately without destructing the sample or using any harm-
ful chemicals. (Appel et al. 2013; Jones et al. 2007; Ho & Hutmacher 2006) 
The method is based on irradiating the sample from the sides with X-rays that are atten-
uated as they travel through the sample. A detector array captures these X-rays with re-
duced intensities. Not only the X-ray paths, but also attenuation coefficients correlating 
to material density can be determined from the detector measurements. As the sample is 
computationally divided into two-dimensional (2D) slices, each attenuation coefficient 
value corresponds to one pixel on 2D pixel maps created from the computations. These 
2D pixel maps expose the material phases in the sample. Using a 3D modeling program, 
the 2D slices can be stacked to create 3D models for visualization. The scanning resolu-
tion typically ranges from 1 to 50µm. (Ho & Hutmacher 2006; Loh & Choong 2013) 
The data sets resulting from micro-CT imaging are large, which is challenging in terms 
of data processing and storage. Other concerns include using ionizing radiation which 
might damage tissues and the fact that micro-CT is not applicable for scaffolds that con-
tain metals. The metals attenuate the X-rays so heavily, that other important details are 
obscured by the resulting grainy artefacts. Furthermore, image thresholding affects the 
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visualization and subsequent analysis, but needs to be done before 3D modeling. If there 
are multiple scaffold materials with overlapping threshold ranges, the digital separation 
of them becomes problematic. (Ho & Hutmacher 2006; Appel et al. 2013) 
Besides analyzing structural features of the scaffolds such as interconnectivity, porosity, 
pore sizes and surface area to volume ratio (Zeltinger et al. 2001; Ho & Hutmacher 2006), 
micro-CT applications include many more such as quantifying bone volumes, mineral 
densities and mineral contents from implanted scaffolds (Mitsak et al. 2011), evaluating 
their osteointegration in bone (Appel et al. 2013), visualizing molecular probes by means 
of enzyme-mediated silver deposition (Metscher & Müller 2011) or characterizing neo-
vascularization with contrast agents like barium sulfate (Appel et al. 2013). The most 
popular application for micro-CT is characterization of tissue engineered bone in cell 
seeded constructs. An increasing amount of new applications in the biomedical field are 
explored to utilize this technique. (Appel et al. 2013; Ho & Hutmacher 2006) 
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4. STEM CELLS 
Stem cells are described to be cells that have the potential for both self-renewal and mul-
tilineage differentiation. Thus, they can produce undifferentiated stem cells and differen-
tiated descendants including functional mature cells. Both scenarios occur in the case of 
asymmetric division, where each stem cell produces one undifferentiated daughter cell 
and one daughter cell with a differentiated fate. Symmetric division results in daughter 
cells destined to the same fate. Stem cells can use symmetric divisions for self-renewal 
or generation of differentiated progeny. Due to their ability to differentiate into multiple 
cell lineages, stem cells are considered to be suitable for tissue engineering and cell ther-
apies. (Yan et al. 2014; Choumerianou et al. 2008; Morrison & Kimble 2006) 
4.1 Stem cell sources and development potential 
One way to classify stem cells sorts them according to their differentiation potential. An 
entire organism can theoretically be created with totipotent stem cells, whereas pluripo-
tent cells have the ability to give rise to all embryonic cell types. Multipotent stem cells 
are able to differentiate into a variety of cellular lineages; oligopotential denotes a more 
limited number of possible developmental directions. Unipotent stem cells such as epi-
dermal stem cells can give rise to one specific cellular lineage only. (Fernández Vallone 
et al. 2013; Fortier 2005; Serakinci & Keith 2006) 
Stem cells can also be classified according to the developmental stage from which they 
are obtained. Embryonic stem cells (ESCs) are pluripotent cells obtained from early-stage 
embryos, as opposed to multipotent adult stem cells that are isolated from adult tissues. 
Unlike other stem cell types, embryonic stem cells can also divide or self-renew indefi-
nitely. Potential therapeutic applications of embryonic stem cells include for example 
spinal cord injuries, myocardial infarction and diabetes. However, their clinical use is 
very limited because of ethical and safety concerns. (Fortier 2005; Dutta 2013; Yan et al. 
2014) 
Adult stem cells are the ethically least controversial stem cell type (Faulkner et al. 2014). 
Found in various differentiated tissues, they are undifferentiated cells having limited self-
renewal and differentiation capacity. Examples of adult stem cells include neural stem 
cells in the central nervous system, skin stem cells, various epithelial stem cells, mesen-
chymal stem cells (MSCs) and skeletal muscle stem cells in muscle fibers. 
(Choumerianou et al. 2008; Fernández Vallone et al. 2013) Since their identification in 
bone marrow in the 1960s, MSCs have been isolated from adipose tissue, heart, liver, 
dental pulp, hair follicles and nearly every other tissue in the body. They have the ability 
to differentiate at least into osteoblasts, chondrocytes and adipocytes. MSCs derived from 
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bone marrow and adipose tissue are the most widely studied adult stem cells. BMSCs 
were the first type of mesenchymal stem cells to be identified. The procedure for harvest-
ing BMSCs is however invasive and painful. (Tsuji et al. 2014; Yan et al. 2014; Liao 
2014; Romagnoli & Brandi 2014) 
In addition to embryonic and adult stem cells, another interesting subgroup, namely in-
duced pluripotent stem cells (iPSCs) has lately been studied a lot. They are adult somatic 
cells that have been reprogrammed into a pluripotent stage being similar to embryonic 
stem cells. The reprogramming can be achieved by transfection of somatic cells with spe-
cific genes. These genes activate and maintain the networks responsible for regulating the 
stemness of the cells. Compared to embryonic stem cells, iPSCs are morphologically and 
antigenically similar but lack ethical problems related to embryonic tissue sources. How-
ever, one significant limitation of iPSCs is their poor reprogramming efficiency. Homog-
enous differentiation to desirable cell types has also been a concern. (Yan et al. 2014; 
Monti et al. 2012; Sánchez Alvarado & Yamanaka 2014; Faulkner et al. 2014) 
Generally, stem cells used for tissue engineering should be available in adequate quanti-
ties via minimally invasive harvesting methods. They should also differentiate into mul-
tiple cellular lineages in a reproducible manner and be safely and effectively transplanted 
to an autologous or allogeneic host. However, stem cells are typically found in low num-
bers and cell death after implantation remains a problem. The fact that large quantities of 
stem cells are rarely available leads to the requirement of their ex vivo expansion before 
clinical use. Furthermore, passaging reduces typically their self-renewal, proliferation and 
differentiation abilities. If the potential of stem cells could be maintained during in vitro 
culture, high numbers of high quality stem cells would be easily available for clinical 
purposes. (Bunnell et al. 2008; Yan et al. 2014; Monti et al. 2012; Romagnoli & Brandi 
2014) 
4.2 Adipose-derived stem cells 
An excellent source for mesenchymal stem cells is the adipose tissue: it is ubiquitous and 
can be harvested with a minimally invasive procedure. The adipose tissue can be har-
vested in large quantities and more importantly, the stem cell yields from adipose tissue 
are higher than those from bone marrow or other stem cell sources: the number of ASCs 
derived from a gram of aspirated tissue ranges typically from 350 000 to 1 000 000, 
whereas one gram of bone marrow aspirate yields normally between 500 and 50 000 
BMSCs. In addition, expanding ASCs in vitro is relatively easy: their average doubling 
time depending on passage number and culture medium is 2-5 days. ASCs can be cryo-
preserved without affecting their proliferation or differentiation. The transcription pro-
files for stem cell phenotype-related genes are practically identical between the ASCs and 
BMSCs. (Barba et al. 2013; Romagnoli & Brandi 2014; Tsuji et al. 2014) 
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4.2.1 ASC characteristics  
Adipose-derived stem cells are not a homogenous population. Comparison and interpre-
tation of studies is difficult due to the lack of standardization among isolation and culture 
procedures. For example, using unpurified stromal vascular fraction instead of purified 
ASCs is a common practice in clinical trials and sometimes used in research as well. 
Standardization of cell culture methods and isolation procedures would increase the reli-
ability and reproducibility of the results, but there are also variables affecting ASC quality 
that cannot be standardized. These include for example donor age, gender, ethnicity, med-
ical history and body mass index. (Tsuji et al. 2014; Romagnoli & Brandi 2014; Locke et 
al. 2011) 
Variations in viability, immunophenotype, proliferation rate and differentiation capacities 
have been found depending on the donor and harvest location. For example, when com-
paring different anatomical sites for harvesting ASCs, it was noted that the osteogenic 
potential of the ASCs isolated from the omentum was higher compared to cells from other 
locations such as subcutaneous or intrathoracic tissue depots. (Russo et al. 2013) On the 
other hand, in another study the ASCs harvested from the superficial abdominal depot 
showed lower susceptibility to apoptosis than the cells obtained from the omental depot. 
(Schipper et al. 2008) 
When comparing the effect of the donor age on ASC proliferation rates and apoptosis 
susceptibility, the youngest patients had fastest cell proliferation rates and the lowest ten-
dency of ASCs to apoptosis. Aksu et al. (2008) noticed faster proliferation and more ef-
fective osteogenic differentiation on male ASCs than female ASCs, whereas van Har-
melen and colleagues (2004) did not find any differences in ASC proliferation or preadi-
pocyte differentiation capacities between male and female samples. (Schipper et al. 2008; 
Van Harmelen et al. 2004; Aksu et al. 2008) 
In addition to the minimal criteria of differentiation into cartilage, bone and adipose tis-
sues, adipose-derived stem cells have been shown to have the potential to differentiate 
into other mesodermal tissues, including tendon, myocardium and skeletal muscle tissues. 
They have also demonstrated to be capable of crossing germinal boundaries by transdif-
ferentiating towards hepatocytes, epithelial cells and kidney cells. The possible ability of 
ASCs to transdifferentiate into neural cells is still somewhat controversial. (Liao 2014; 
Barba et al. 2013) 
One additional interesting property of ASCs is their immunosuppressive potential: by 
secreting specific signaling proteins like prostaglandins or interleukins, ASCs can reduce 
the maturation of certain immune cells and suppress inflammation. Moreover, they have 
been shown to modulate immune responses by direct cell-cell contacts. This all makes 
ASCs an attractive alternative for applications related to transplantations or immune dis-
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orders. Clinical trials for repairing fistula from Crohn’s disease have already been per-
formed. Another possible application for the immunosuppressive properties of ASCs is 
osteoarthritis, as inflammation is one component of the condition. The possible drawback 
of immunomodulation or immunosuppression is possible cancer cell development due to 
downregulated antitumor immune cells. (Schmitt et al. 2012; Kokai et al. 2014; 
M.B. Murphy et al. 2013) 
4.2.2 Characterization 
In 2006, the International Society for Cellular Therapy (ISCT) proposed minimal criteria 
to define MSCs. According to the statement, ≥95% of the cell population should express 
cluster of differentiation (CD) antigen surface molecules CD105, CD73 and CD90, 
whereas ≥2% must lack the expression of CD45, CD34, CD14 or CD11b, CD79α or 
CD19 and human leukocyte antigen (HLA) class II. Expression of the markers can be 
measured using flow cytometry. In addition, MSCs need to be plastic-adherent under 
standard culture conditions in tissue culture flasks and must be able to differentiate in 
vitro to adipocytes, osteoblasts and chondroblasts in standard differentiating conditions. 
(Dominici et al. 2006) In Figure 8, adipose-derived stem cells adhered onto a polystyrene 
cell culturing flask are presented.  
 
Figure 8. Adipose-derived stem cells adhered onto a polystyrene cell culturing flask. 
Scale bar 1mm. 
The ISCT statement was updated in 2013, when ISCT together with the International 
Federation for Adipose Therapeutics (IFATS) gave guidelines for better characterizations 
of adipose-derived stromal and stem cells. Phenotypical identification of the stromal cells 
as uncultured SVF requires expression of the marker CD34 and lack of expression in the 
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case of markers CD45, CD235a and CD31. A viability marker and surface antigens 
CD13, CD73, CD90 and CD105 may provide added value for the identification. ASCs in 
culture remain positive for markers CD90, CD73, CD105 and CD44 which are common 
with other MSCs, but do not express markers CD45 and CD31. Positivity for CD36 and 
negativity for CD106 distinguishes ASCs from BMSCs. (Bourin et al. 2013) Table 1 
summarizes the surface marker expression criteria from 2006 and 2013. 
Table 1. A summary of the surface marker expression criteria for partly defining ASCs. 
In this work, the characterization was done using the criteria from 2006. (Bourin et al. 
2013; Dominici et al. 2006) 
Surface Marker 
ISCT 2006 criteria          
(Surface marker expression) 
ISCT & IFATS  2013 criteria 
(Surface marker expression) 
CD11b or CD14 
CD19 or CD79α 
CD31 
CD34 
CD44 
CD45 
CD73 
CD90 
CD105 
HLA-DR 
≤ 2% 
≤ 2% 
- 
≤ 2% 
- 
≤ 2% 
≥ 95% 
≥ 95% 
≥ 95% 
≤ 2% 
- 
- 
≤ 2% 
- 
≥ 95% 
≤ 2% 
≥ 95% 
≥ 95% 
≥ 95% 
- 
4.2.3 ASC differentiation into osteogenic lineages 
Although logical and sometimes functional, using readily differentiated cells like osteo-
blasts for bone regeneration entails problems. One of those is the limited amount of tissue 
for cell isolation. For this reason, either multipotent or pluripotent stem cells have been 
thought to be the most suitable cell alternatives for tissue engineering. The ability of ASCs 
to differentiate into osteogenic lineages makes them a potential alternative for orthopedic 
applications. (Salgado et al. 2013; Tirkkonen et al. 2012) 
A typical strategy for tissue regeneration using ASCs involves their in vitro differentiation 
before implantation (Kokai et al. 2014). The differentiation can be achieved for example 
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by applying chemical (Mesimäki et al. 2009; Zhang et al. 2012), electrical (Pelto et al. 
2013), electromagnetic (Kang et al. 2013), mechanical (Tirkkonen et al. 2011) or scaffold 
(Salazar & Ohneda 2012; Yan et al. 2014) stimuli. Commonly used chemical agents for 
osteogenic differentiation of ASCs include ascorbic acid, dexamethasone and β-glycer-
ophosphate. For example, Tirkkonen et al. (2013) have used a medium optimized for 
ASCs, which is supplemented with these substances. (Fiorentini et al. 2011; Tirkkonen et 
al. 2012) 
Enhancing the osteogenic capacity of ASCs has largely focused on growth factors like 
bone morphogenetic proteins (BMPs). Yet their cost-effectiveness and safety are ques-
tioned, and there have been doubts whether these cells respond to BMPs at all. For exam-
ple, Tirkkonen et al. noticed no benefit from adding growth factors BMP-2, BMP-7 or 
vascular endothelial factor (VEGF) into the osteogenic medium when it comes to cell 
number and osteoinduction of ASCs. In addition, the growth factor doses required in the 
clinical use are large, making their usage very expensive. (Kyllönen et al. 2013; 
Tirkkonen et al. 2012) 
Since most of the cells are anchorage-dependent, the chemical composition and the prop-
erties of the scaffold material play an important role in tissue engineering. In scaffold-
stimulated bone regeneration, the material should not only be osteoconductive thus al-
lowing bone growth on its surface, but ideally be osteoinductive thereby stimulating os-
teogenic differentiation of cells. For example certain bioceramics are osteoinductive. Also 
the surface topography of the scaffold material is of great importance concerning stem 
cell differentiation. (Albrektsson & Johansson 2001; Salazar & Ohneda 2012; Yan et al. 
2014) 
4.2.4 ASCs in bone tissue engineering 
Originally, stem cells were applied directly into the bone fracture site. Adipose-derived 
stem cells have been noted to have the ability to migrate towards the injured tissue, pos-
sibly by means of chemoattractants released after tissue damage. Although injecting stem 
cells has been demonstrated to promote bone regeneration as well, it is ineffective in cases 
of large defects or non-union of bone. Hence, scaffolds seeded with cells are nowadays 
preferred instead of cell therapy. The reason for this lies in the ability of the scaffolds to 
provide support for cell growth, migration and differentiation. (Romagnoli & Brandi 
2014; Kokai et al. 2014; Qin et al. 2014) 
When it comes to clinical applications of bone tissue engineering, adipose-derived stem 
cells have been used especially in reconstructing or accelerating skull and jaw defects. 
They were successfully used in bone tissue engineering only a few years after their dis-
covery, when Lendeckel et al. applied ASCs with spongy bone and fibrin glue to large 
defects in a 7-year old girl’s skull. Three months after the operation, nearly complete 
continuity of the fragments in the skull was shown. A bit later, a 65-year-old male patient 
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was treated with a combination of β-TCP, autologous ASCs and BMP-2. The patient’s 
lost upper jaw was replaced with a construct of these materials that was first grown inside 
the patient’s abdominal muscle. The healing was uneventful during the 36 months follow-
up period. Ever since, multiple patients with cranio-maxillofacial defects have been 
treated in Finland with bioactive glass or β-TCP scaffolds seeded with ASCs. 10 out of 
13 reported cases were successful with demonstrated hard-tissue integration of the seeded 
cell-scaffold constructs at the defect sites. (Romagnoli & Brandi 2014; Lendeckel et al. 
2004; Mesimäki et al. 2009; Sándor et al. 2014) 
So far, clinical studies have shown adipose-derived stem cells to be safe and to possess 
the potential for tissue repair. Standardizing harvest, isolation and culturing of the cells 
would make the comparison of different studies easier. Also the effect of different scaf-
folds on ASC osteogenesis has been investigated in numerous studies, suggesting the use 
of different materials, structures and fabrication materials. Despite their potential, further 
results are needed from long-term human series and animal models. (Kokai et al. 2014; 
Romagnoli & Brandi 2014; Sándor et al. 2014) 
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EXPERIMENTAL PART 
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5. MATERIALS AND METHODS 
In this study, 6 different cell seeding methods were tested on 4 different types of porous 
biomaterial scaffolds. Human adipose-derived stem cells were used in the cell seeding 
experiments. Iron-labeled microspheres were used to estimate the structure and pore in-
terconnectivity of two scaffold types. The viability and the distribution of the cells were 
evaluated qualitatively, whereas the cell number analysis was quantitative. 
5.1 Scaffold fabrication 
The 4 different scaffold types (diameters 10 mm or 12 mm) are presented in Figure 9. 
Sc-PLCL and Sc-COMP50 were processed with supercritical CO2. 
 
 Figure 9. Different scaffold types with diameters of 10 mm and 12 mm, as used in the 
experiments. In the knitted PLDLA 96/4 scaffolds, an unrolled piece of knit is shown in 
the back. Similarly, a small piece of the non-woven fabric is seen on the right of the non-
woven PLDLA 96/4 image. 
The cylindrical-shaped scaffolds had heights ranging from about 2.5 mm to 3.5 mm de-
pending on the scaffold type. All the scaffolds were sterilized before cell experiments by 
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gamma irradiation (BBF Sterilisationsservice GmbH, Kernen-Rommelshausen, Ger-
many) with a minimum dose of 25 kilograys (kGy).  
Copolymeric SC-PLCL scaffolds were processed from poly(L-lactide-co-ε-caprolac-
tone) 70/30 (Corbion Purac, Gorinchem, The Netherlands). The general porosity of the 
PLCL scaffolds was 65% with an average pore size of 430±170 μm and a maximum pore 
size of 1100 μm, analyzed from the micro-CT data. Sc-COMP50 composite scaffolds 
contained 50 weight-% PLCL 70/30 (Corbion Purac) and 50 weight-% β-tricalcium phos-
phate granules (Plasma Biotal, Tideswell, The United Kingdom) of sizes ranging from 
100 to 300 μm. Sc-COMP50 porosity showed a similar percentage of 65% with an aver-
age pore size of 370±150 μm and the biggest pore size at 950 μm. Both supercritical CO2 
processed scaffold types were cut into their final height of approximately 3 mm using a 
scalpel. 
The non-woven PLDLA fabric scaffolds were manufactured from PLDLA 96/4 (Purac 
Biochem; currently Corbion Purac, Gorinchem, The Netherlands). The fibers were man-
ufactured by extrusion and had a diameter of approximately 13 µm. They were first 
carded and then needle punched into a non-woven fabric structure using 4 layers of card. 
The PLDLA fabric was washed 2 times 4 minutes in 99.5% alcohol (Etax Aa; Altia, Ra-
jamäki, Finland) in an ultrasonic cleaner (FinnSonic, Lahti, Finland), after which the scaf-
folds with diameters of 10 mm and 12 mm were punched from the moist fabric. The 
scaffolds were then dried at room temperature. The average height of dry non-woven 
scaffolds was measured to be around 2.5 mm, although there was significant variation 
between different scaffolds.  
The knitted PLDLA scaffolds were also made from PLDLA 96/4 (Purac Biochem). The 
4-filament fibers were manufactured by extrusion and knitted later using special machin-
ery. The fiber diameter was approximately 70 μm. In Figure 9, a piece of the knit can be 
seen behind the scaffolds. Suitable lengths were cut from the knit with respect to the 
desired scaffold size. The knits were then rolled into cylindrical shapes and the ends were 
fixed to the roll by heat sealing. Finally, the knitted scaffolds were heat treated for 30 
minutes at 80°C in a mold to obtain their final shape. Depending on the width of the knit, 
the scaffold heights varied to some extent. Being the most common value, an average 
height of 3.6 mm was used in the calculations when dealing with the knitted scaffolds. 
5.2 A novel cell seeding model with iron-labeled microspheres 
and micro-CT 
Iron-labeled microspheres (FerroTRACK; BioPAL Inc., Worcester, MA, The United 
States) of sizes 15 µm and 100 µm were used in the preliminary modeling tests. The tests 
were conducted using ScCO2 processed scaffolds to model their seedability and pore in-
terconnectivity. The aim of this analysis was to confirm that the microspheres are able to 
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infiltrate into the pores in different depths of the scaffold, and to test the hypothesis of 
modeling cell seeding with these particles. 
The scaffolds were pre-wetted in distilled water (Milli-Q Biocel A10; Millipore, Mol-
sheim, France) before seeding (pre-wetting is described in section 5.4.1) and incubated in 
a +37°C water bath for some hours before seeding the microspheres. 10 000 particles with 
a diameter of 100 µm were seeded per scaffold. In the case of 15 µm particles, a number 
of 60 000 microspheres was used. Thus, when interpreting the results it must be taken 
into account, that the combined total volume of the larger particles is almost 50 times 
higher than that of the smaller 15 µm particles. 
Before seeding the microspheres, their saline buffer was changed into distilled water to 
prevent salt crystal formation when drying the sample (salt crystals could disturb micro-
CT imaging results). This was done by centrifuging the microspheres to the bottom of a 
microcentrifuge tube, removing the supernatant and washing the microspheres with dis-
tilled water. After repeating this cycle several times, the particles were suspended in 50 µl 
of distilled water and seeded to the top surface of the scaffold using the static seeding 
method (presented in section 5.4.2.). The scaffolds were left to dry for at least 2 days in 
room temperature before they were imaged using micro-CT technology. The scaffolds 
were imaged individually and the resolution range used was from 5.0 to 6.0 µm. 
5.3 Cell isolation and culture 
Cell culturing was performed in the Adult Stem Cell Group laboratories at the Institute 
of Biosciences and Medical Technology (BioMediTech), University of Tampere. The 
cells were cultured in an incubator (Binder CB210; Binder GmbH, Tuttlingen, Germany) 
in a humidified atmosphere at +37°C with 5% CO2.                       
5.3.1 Human adipose-derived stem cell isolation 
Human adipose-derived stem cells (hASCs) were isolated from adipose tissue samples 
derived from 3 different female donors aged between 32-49 years. The adipose tissue was 
obtained from the patients in accordance with the Ethics Committee of Pirkanmaa Hos-
pital District (Tampere, Finland). Using scissors, the samples were first chopped small 
and transferred into 50 ml falcon tubes (Cellstar; Greiner Bio-One, Switzerland). Fibrous 
and bloody sites were avoided.  
The samples were then digested using collagenase type I (1.5 mg/ml; Invitrogen, Carls-
bad, CA, The United States) at +37°C. After centrifuging (10 min, 1800 rpm) with La-
bofuge 400R centrifuge (Kendro Laboratory Products, Osterode, Germany), the resulting 
pellet was filtrated (Cell Strainer 100 µm nylon filter; BD Falcon, Franklin Lakes, NJ, 
The United States) and the red blood cells were lysed in 1 ml of sterile water (Baxter 
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Healthcare SA, Zürich, Switzerland), after which 9 ml of medium was added. After cen-
trifuging again (10 min, 1800 rpm), the new pellet was suspended in 10 ml of medium, 
filtrated and transferred into T75 cell culturing flasks. The flasks were placed into the 
incubator at +37°C and washed twice with Dulbecco’s Phosphate Buffered Saline (DPBS; 
Lonza, Verviers, Belgium) the next day. 
5.3.2 Characterization of the adipose-derived stem cells 
The identification and characterization of the human adipose-derived stem cells was per-
formed at passage 1 after cell isolation and it was done by BioMediTech laboratory spe-
cialists. All the three cell lines that were used in the experiments were analyzed. The flow 
cytometric surface marker expression analysis was performed with a fluorescent-acti-
vated cell sorter (FACSAria; BD Biosciences, Erembodegem, Belgium) using 10 000 
cells per sample. 
The probes used in the FACS analysis included monoclonal antibodies against CD3-Phy-
coerythrin (PE), CD14-Phycoerythrin-Cyanine (PE-Cy7), CD19-PE-Cy7, CD45R0-Al-
lophycocyanin (APC), CD54-fluorecein isothiocyanate (FITC), CD73-PE, CD90-APC 
(BD Biosciences, San Jose, CA, The United States); CD11a-APC, CD80-PE, CD86-PE, 
CD105-PE (R&D systems, Minneapolis, ME, The United States); CD34-APC and HLA-
DR-PE (Immunotools GmbH, Friesoythe, Germany). 
5.3.3 Cell maintenance and passaging 
The cells were cryopreserved in nitrogen gas phase storage and thawed when needed in a 
+37°C water bath. Since the freezing solution contained dimethyl sulfoxide (DMSO; 
Sigma Aldrich, St. Louis, MO, The United States), the cells were suspended immediately 
after thawing in 6 ml of cell culturing medium, centrifuged for 5 minutes at 1000 rpm, 
suspended into 10 ml of cell culturing medium and put into a T75 cell culturing flask 
(Nunc, Roskilde, Denmark). The cell culturing medium was optimized for hASCs and 
composed of Dulbecco’s Modified Eagle Medium (DMEM/F-12 1:1; Gibco by Life 
Technologies, Paisley, The United Kingdom) supplemented with 1% L-glutamine (Glu-
taMAX; Gibco by Life Technologies), 5% Human Serum type AB (Paa Laboratories 
GmbH, Pasching, Austria) and 1% penicillin-streptomycin antibiotics (Biowhittaker Pen-
Strep; Lonza). 
The culturing medium for the cells was changed every 3 or 4 days. Typically half of the 
medium in each flask was changed, but in case it was desirable to try to hinder cell pro-
liferation, the whole amount was changed. When confluent, the cells were passaged by 
washing the cells first with 5 ml of DBPS (Lonza) and then detaching the cells using 3 ml 
of TrypLE Select enzymes (Gibco by Life Technologies, Grand Island, NY, The United 
States). The cells were incubated with TrypLE Select (Gibco by Life Technologies) for 
approximately 10 minutes at +37°C. The enzyme was inactivated with 6 ml of medium 
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per each flask, the suspensions were collected and centrifuged for 5 minutes at 1000 rpm. 
The resulting cell pellet was then suspended in medium and divided into new cell cultur-
ing flasks containing altogether 10 ml of medium per flask. 
5.3.4 USPIO-labeling of the cells 
Ultrasmall Superparamagnetic Iron Oxide (USPIO) nanoparticles (Magnetizable 50nm 
nanoparticles, 25 mg/ml; Kisker GmbH, Steinfurt, Germany) were used to label hASCs 
in order to make them visible in micro-CT images. The amounts of USPIO particles used 
were based on optimization tests of M.Sc. Mimmi Patrikoski. 
The cells were first left to attach and accommodate in their culturing flasks for 3 or 4 
days, after which their number was estimated using a light microscope (Nikon Eclipse 
TE2000-S; Nikon Instruments Europe). For this work, the cell number estimations were 
provided by BioMediTech laboratory technologist Anna-Maija Honkala. Based on the 
estimated number of cells, the amount of nanoparticles were calculated using 1000 µg of 
USPIO particles per 100 000 cells as a basis. The nanoparticles were diluted in cell cul-
turing medium to a concentration of 1 mg/ml of USPIO particles. Poly-D-lysine (PDL, 
1 mg/ml; Millipore) was then added to an extent of 3750 ng per 100 000 cells. 
The working solution obtained was incubated in room temperature for 3×10 minutes, 
mixing it gently after every 10 minutes. During this incubation, poly-D-lysine should at-
tach to the USPIO nanoparticles and thus facilitate the uptake of nanoparticles into the 
hASCs. Finally, this working solution was diluted with medium to a final USPIO nano-
particle concentration of 200 µg/ml. The culturing medium of the cells was then replaced 
with this USPIO-PDL solution. After an incubation of 48 hours, the USPIO-PDL medium 
was removed and replaced with 10 ml of fresh medium to let the cells recover. Figure 10 
presents adipose-derived stem cells just before adding the USPIO-PDL medium and 
48 hours after adding the USPIO particles. 
 
Figure 10. Light microscopy images of hASCs in a cell culturing flask (A) just before and 
(B) 48 hours after USPIO-labeling. Scale bars 100 µm. 
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The cells were allowed to recover for 1 day in fresh media before they were seeded. In 
addition to seeding cells into scaffolds, an applicable number of USPIO-labeled hASCs 
were seeded on a glassy cover slip on a 6-well plate with 3 ml of cell culturing medium. 
The cover slip was cultivated for 3 days like the scaffolds, after which the Prussian blue 
staining was performed to evaluate the success of the USPIO-labeling. 
5.4 Cell seeding methods 
The 6 different cell seeding methods used in this work are explained in this chapter. A 
graphic illustration of the methods is provided in Figure 11. 
 
 Figure 11. Illustration of the cell seeding methods used in this work. 
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After cultivating and expanding human adipose-derived stem cells in sufficient amounts, 
the cells were detached from their flasks as in passaging (section 5.3.3) and counted using 
a Bürker chamber. Based on the estimated scaffold volumes, different numbers of cells 
were used in each scaffold. As presented later in Table 3, a total of 3 experiments were 
made with the ScCO2 processed scaffolds, whereas the analyses were done only once 
with the PLDLA 96/4 scaffolds. The experiment series was started exceptionally by seed-
ing 60 000 hASCs into Sc-PLCL scaffolds, but the rest of the experiments were done with 
an increased cell number of 120 000, as implied in Table 2. 
Table 2. Scaffold volumes and cell amounts used. The 12 mm scaffolds were used in the 
two syringe methods.  
 
The cell seeding density indicates the amount of cells found per cubic millimeter of a 
scaffold in an ideal case where all the cells are attached to the scaffold. The cell numbers 
were chosen based on the scaffold volumes with the aim of getting a similar cell seeding 
density. It needs to be taken into account, that also scaffolds with a diameter of 12 mm 
were used with the syringe cell seeding methods. The amount of cells was still kept the 
same, which led to a different cell seeding density. 
5.4.1 Scaffold pre-wetting 
Before cell seeding, the scaffolds were pre-wetted in cell culture medium 2 days in ad-
vance. This was done by adding approximately 20 ml of cell culture medium into a 50 ml 
falcon tube (Greiner Bio-One) and adding an applicable number of scaffolds, typically 
Scaffold type 
The amount 
of cells 
seeded  
Average 
scaffold 
height 
Average 
scaffold 
volume 
(V=π·r2·h, 
ᴓ=10mm)  
Average scaf-
fold volume 
(V=π·r2·h, 
ᴓ=12mm)  
Cell seeding 
density 
(ᴓ=10mm) 
Cell seeding 
density 
(ᴓ=12mm) 
Sc-PLCL 
60 000 /        
120 000 
3.0 mm 75π mm3 108π mm3 509 cells/mm3 354 cells/mm3 
Sc-COMP50 120 000 3.0 mm 75π mm3 108π mm3 509 cells/mm3 354 cells/mm3 
Non-woven 
PLDLA 96/4 
100 000 2.5 mm 62,5π mm3 90π mm3 509 cells/mm3 354 cells/mm3 
Knitted 
PLDLA 96/4 
144 000 3.6 mm 90π mm3 130π mm3 509 cells/mm3 354 cells/mm3 
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from 10 to 12. The bottom of the falcon tube was knocked against a table until the scaf-
folds had sunken to the bottom of the tube. This indicated that the air in the scaffold pores 
was removed and replaced by medium. The scaffolds were then transferred to 24 well-
plates (Nunc) with 1 ml of medium per each well, after which the plates were kept in an 
incubator at +37°C until the cell seeding process. This was done to enable protein adsorp-
tion from the medium to the scaffold. 
5.4.2 Static method 
In the static seeding method, an appropriate number of cells in a volume of 50 µl cell 
suspension were pipetted to the top surface of the scaffold. In practice, the surface of the 
scaffold was touched with the cell suspension drop hanging from the pipette tip. Typi-
cally, 50 µl of cell suspension corresponded to 3-5 drops of cell suspension that were 
spread as evenly as possible to the surface of the scaffold. This widely used static cell 
seeding method was considered as a control method.  
5.4.3 Squeezing method 
The squeezing method was based on the assumption of getting a more homogenous cell 
distribution by inducing suction inside the scaffold, created by the elastic nature of the 
scaffolds. The scaffold was first put into a small gamma-sterilized (25 kGy, BBF Sterili-
sationsservice GmbH) plastic “squeezing pouch”. It was first squeezed from the sides 2×5 
times before adding any cells. The squeezing was done using an index finger and a thumb: 
the scaffold was squeezed from the sides five times with a relatively fast release after 
each squeeze. After five squeezes, the scaffold was rotated 90º around its axis and the 
squeezing was repeated. The squeezing directions are illustrated in Figure 11. 
The scaffold was then oriented so that its top surface was pointing up towards the opening 
of the pouch. The cells in a volume of 50 µl were pipetted onto the top surface similarly 
to that on static seeding. In practice, it was more difficult to spread cell suspension to the 
perimeter of the scaffold surface, because the cell suspension drop adhered easily to the 
sides of the squeezing pouch. After spreading the cell suspension to the top, the scaffold 
was again squeezed 2×5 times. The squeezing was done in a similar manner compared to 
the pre-cell pipetting phase. 
5.4.4 Centrifugation method 
Centrifugation seeding was performed by pressing the scaffold gently from its sides to fit 
a 15 ml falcon tube (Cellstar; Greiner Bio-One). The fit was supposed to be tight enough 
to prevent the cell suspension from flowing to the bottom of the tube before centrifuga-
tion, but loose enough to not close the porous structure of the scaffold. A cell suspension 
volume of 1000 µl with an applicable cell amount was then pipetted on top of the scaffold 
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and centrifuged for 5 minutes at 1000 rpm. After centrifugation, the cell suspension had 
flowed to the bottom of the tube as in the Figure 11. 
5.4.5 Injection method 
In a preliminary test, it was noticed that a liquid volume of approximately 10 µl was left 
inside the syringe. That led to choosing a cell suspension volume of 110 µl for the injec-
tion method. Using an injection needle (KD Medical GmbH, Berlin, Germany) and a 1 ml 
syringe (Omnifix-F; B.Braun Melsungen AG, Melsungen, Germany), the aim was to in-
ject 20 µl of cell suspension evenly into five different spots in the scaffold. The pattern 
of the injection sites is presented in Figure 11. The injection needle was not pressed all 
the way through the scaffold in order to prevent the cell suspension from flowing out from 
the bottom of the scaffold. 
5.4.6 Syringe 1 method 
The principal idea behind the two different syringe methods is close to that of the centrif-
ugation method: to force the flow of cell suspension through the pores of the scaffold. In 
syringe 1 method, the plunger of the syringe (BD Discardit II; Becton Dickinson, 
Mequinenza, Spain) was pulled out, the scaffold was placed into the syringe using twee-
zers and 1000 µl of cell suspension was pipetted to the top of the scaffold. The plunger 
was then pushed until it almost touched the scaffold to create pressure that would possibly 
enable the cells to go deeper into the pores of the scaffold. The principal idea was to keep 
the scaffolds at the 2 ml mark instead of letting them slide to the bottom. This was done 
by gently pressing the syringe from outside with two fingers. However, only the Sc-
COMP50 scaffolds fitted the syringe tightly enough to permit this. For this method, scaf-
folds with diameters of 12 mm were used. 
5.4.7 Syringe 2 method 
In the syringe 2 method, a syringe (Becton Dickinson) was taken and its tip was cut off 
using a sterile scalpel. The scaffold was placed into the syringe from the newly formed 
opening, after which 1000 µl of cell suspension was pipetted to the top of the scaffold. A 
plunger from a new syringe was taken and used to push the cell suspension through the 
scaffold. This phase was repeated altogether 3 times. After each cycle, the syringe system 
was always turned in a way that the cell suspension was above the scaffold. Each time 
the upper plunger was pushed and the lower one only controlled in a manner that prevents 
it from falling off the system. The scaffold was kept still by pushing the syringe from the 
sides, as in the syringe 1 method. Again, some of the scaffolds did not hold still, which 
changed the nature of the seeding method. For this method, scaffolds with diameters of 
12 mm were used. 
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5.4.8 Post cell seeding treatment 
After the seeding process, the cell-scaffold constructs were transferred to clean, dry 
24-well plates in order to discard the cells that did not reach the scaffold. The constructs 
were incubated at +37°C to enable cell attachment. After an incubation of 3±0.5 hours, 
1 ml of fresh medium per well was added. The constructs were then cultured for 3 days 
before performing the analyses. 
5.5 Analyses 
All the analyses were performed at a time point of 3 days after cell seeding. Cell distri-
bution and cell viability were assessed qualitatively, whereas the cell number analysis 
was quantitative. The amount of experiments performed on each scaffold type is pre-
sented in 0. Essentially, microsphere analyses were only performed for the supercritical 
CO2 processed scaffolds: both microsphere sizes of 15 μm and 100 μm were tested on Sc-
PLCL, whereas only the larger 100 μm microspheres were tested on Sc-COMP50 scaf-
folds. The cell seeding experiments were carried out with 3 different cell lines when it 
comes to these scaffolds. Only one cell line was used for the two PLDLA scaffold types. 
Table 3. The number of experiments performed on each scaffold type. 
Scaffold type 
Cell seeding model 
with iron-labeled    
microspheres 
Cell viability and 
2D distribution 
(Live/Dead) 
Cell number 
(CyQUANT) 
3D cell     
distribution  
(Micro-CT) 
Sc-PLCL 15 µm and 100 μm 3x 3x 3x 
Sc-COMP50 100 μm 3x 3x - 
Non-woven 
PLDLA 96/4 
- 1x 1x 1x 
Knitted 
PLDLA 96/4 
- 1x 1x 1x 
5.5.1 Cell viability and distribution in 2D (Live/Dead staining) 
The viability of the cells as well as their attachment and distribution on the top, bottom 
and cross section of the scaffolds were studied using Live/Dead staining at the time point 
of 3 days after cell seeding. For each cell seeding method, 2 parallel Live/Dead specimens 
were used. 
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The method is based on two probes, calcein acetoxymethyl ester (calcein AM) that pro-
duces a green fluorescence in live cells and ethidium homodimer-1 (EthD-1) inducing a 
red fluorescence in dead cells. The cell permeable calcein AM is conversed to fluorescent 
calcein by intracellular esterase activity in live cells, whereas EthD-1 cannot permeate 
through an intact cell membrane of viable cells. EthD-1 enters thus only cells with dam-
aged membranes and binds to nucleic acids, which results in a 40-fold increase in fluo-
rescence of the dye. (Invitrogen Molecular Probes 2005) 
The seeded scaffolds were washed once gently with DPBS, after which 1 ml of Live/Dead 
working solution per scaffold was added. They were then dark incubated at room temper-
ature in gentle shaking for 45 minutes. The working solution was a mixture of 0.25 mM 
EthD-1 and 0.5 mM calcein AM (LIVE/DEAD Viability/Cytotoxicity Kit for mammalian 
cells; Invitrogen Molecular Probes, Eugene, OR, The United States) in DPBS prepared 
according to the manufacturer’s instruction.  
After incubation, the working solution was replaced with DPBS and the scaffolds were 
imaged using a fluorescence microscope (Olympus IX51). The top and bottom of each 
scaffold was always first imaged, after which the scaffold was cut vertically along the 
diameter of the top surface using a scalpel. The cross sectional area was then imaged as 
3 different images and arranged later computationally into one continuous image. Living 
cells appeared green in the images, dead cells correspondingly showed red fluorescence. 
5.5.2 Quantitative cell proliferation assay (CyQUANT assay) 
In order to evaluate the amount of hASCs in the seeded scaffolds 3 days after the seeding 
process, CyQUANT cell proliferation assay was utilized. The method is based on a 
CyQUANT GR fluorescent dye, which binds to cellular nucleic acids. The content of 
nucleic acids in the culture reflects the number of cells. For each cell seeding method, 3 
parallel specimens were used with 3 parallel samples measured from each specimen. 
At the time point of 3 days after cell seeding, the scaffolds were washed once gently with 
DPBS and transferred then to clean 24-well plates. 500 µl of 0.1% Triton-X-100 (Sigma-
Aldrich) in DPBS was then added per culture well. The well plates were stored at -70°C 
for at least 1 day to enable efficient cell lysis. They were then thawed at room temperature 
and the buffer solution was pipetted 5 times on both sides of the scaffolds in order to 
incorporate all the cells also from inside the scaffolds into the analysis. After this, the 
well plates were frozen again at -70°C and then thawed in a similar manner before starting 
the analysis. 
The triton lysates were collected into small microcentrifuge tubes and centrifuged shortly 
for 5 seconds. Out of each individual specimen, 3 parallel samples of 20 µl were pipetted 
into a 96-well plate (Nunc). Then, 180 µl of CyQUANT working solution was added. The 
working solution was prepared using distilled water, CyQUANT GR dye and cell-lysis 
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buffer (CyQUANT Cell Proliferation Assay Kit; Life Technologies) according to the 
manufacturer’s instructions. The air bubbles were broken using a pipette tip and the sam-
ples were protected from light. The fluorescence measurement was done using a multi-
plate reader (Victor 1420 Multilabel Counter; Wallac, Turku, Finland).  
5.5.3 3D cell distribution of the USPIO-labelled cells (Micro-CT) 
A novel method for evaluating the 3D cell distribution inside scaffolds after cell seeding 
was designed: adipose-derived stem cells were labeled with USPIO particles (labeling 
process described in section 5.3.4.) and then seeded into the scaffolds. The cells were 
fixed to the scaffold after 3 days of cultivation. The scaffolds were then imaged using 
micro-CT technology, which detects the iron oxide nanoparticles inside the cells provid-
ing an insight into the distribution of the cells. When imaging single scaffolds, the micro-
CT resolution range was typically between 5.0 - 6.0 µm. Multiple scaffolds were imaged 
with resolutions in the range of 17.0 – 18.0 µm. 
Before starting the actual cell seeding experiments, preliminary tests were performed by 
seeding 3 500 ASCs into a well on a 48-well plate (Nunc). The cells were then USPIO-
labeled according to the protocol - the amounts of USPIO-labeling reagents were calcu-
lated using 3 500 cells as a reference instead of estimating the true number of cells on the 
well. The cells were then fixed, washed and dried before imaging the sample. These steps 
were done in a similar manner than with the scaffolds, described next. After the well-
plate test, also preliminary scaffold test was performed by seeding 60 000 USPIO-labeled 
cells statically into a Sc-PLCL scaffold. The cells were fixed after 1 day instead of the 3-
day time point used later in the experiments. 
In the actual experiments, the USPIO-labeled cells in the scaffolds were first fixed with 
4% paraformaldehyde and washed 3 times with DPBS afterwards. In order to prevent salt 
crystal formation that could disturb micro-CT imaging, the external salts originating from 
DPBS were removed from the scaffold. This was done by incubating the scaffolds in 
0.1% Tween 20 (Sigma-Aldrich) in DPBS for 1 hour at room temperature in a gentle 
shaking, rinsing the scaffolds first with distilled water, washing 3 times with distilled 
water in gentle shaking for 4 minutes and finally removing the water and letting the sam-
ples dry. Dry scaffolds were then imaged using a micro-CT scanner (MicroXCT-400; 
Xradia, Pleasanton, CA, United States). 
5.5.4 Prussian blue staining for iron  
The Prussian blue staining was performed to assess the presence of iron inside the cells, 
that is, to evaluate the level of success in USPIO-labelling. After seeding the USPIO-
labeled ASCs into the scaffolds, a glass coverslip was placed into a 6-well plate (Costar; 
Corning Incorporated, Corning, NY, United States) with 3ml of cell culturing medium, 
after which approximately 70 cells/mm2 were seeded onto the coverslip. 
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On the day of the experiment time point, the cells on the coverslip were fixed with 2.5% 
glutaraldehyde (25% glutaraldehyde in H2O; Sigma-Alrich) in H2O for 10-15 minutes. 
The cells were then stained in an equal mix of 10% potassium ferrocyanide in H2O and 
20% HCl in H2O by immersing the coverslip in the solution for 20 minutes. After 3 
washes in distilled water, the cells were counterstained with Nuclear Fast Red (Sigma-
Aldrich, Egham, The United Kingdom) for 5 minutes, rinsed twice with distilled water 
and dehydrated through 95% alcohol (Etax Aa diluted in distilled water) and 2 changes 
in 99.5% alcohol (Etax Aa; Altia). After clearing the sample 2 times 3 minutes in xylene, 
the coverslip was fixed onto a glass plate with vectamount (Eukitt; O.Kindler GmbH & 
CO, Freiburg, Germany). The sample was then imaged with light microscopy – bright 
blue indicated the presence of iron, whereas cell nuclei and cytoplasm were colored red 
and pink, respectively. 
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6. RESULTS 
6.1 Pore interconnectivity analysis with microspheres 
The distribution of the iron-labeled microspheres was determined from the micro-CT im-
ages. Figure 12 shows 15 µm microparticles being relatively evenly distributed inside the 
scaffold. 
 
Figure 12. Micro-CT image of a Sc-PLCL scaffold seeded with 15µm iron-labeled mi-
crospheres. The image is taken from the side of the scaffold with microspheres appearing 
goldish on the bottom of the pores. 
Altogether 60 000 microspheres were statically seeded, but instead of the whole scaffold, 
only part of the scaffold (approximately 6×6×3 mm in size) was imaged in order to obtain 
a better resolution and thus ensure the visibility of the particles. Figure 12 obviously 
shows crescent-shaped clusters of iron-labeled microspheres in different depths of the 
scaffold. It was thus clear, that the interconnectivity of the pores in these scaffolds is on 
a good level. A similar test was performed with 10 000 microspheres with a size of 
100 μm. The result is shown in Figure 13, with the whole scaffold being imaged. Similarly 
to the previous Figure 12, the 3D view is from the side with the scaffold material partly 
faded to see the microspheres in the pores. 
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Figure 13. Iron-labeled microspheres with a diameter of 100 μm inside a Sc-PLCL scaf-
fold. The whole scaffold is seen in the image in a dark purple color.  
Again, the microspheres ended up into the pores deep in the scaffold confirming the result 
of good pore interconnectivity. The lower corners of the scaffold are emptier: this might 
be due to pipetting the particles in a center-oriented way. Nonetheless, in general the par-
ticles have occupied the scaffold evenly. This also indicates that most of the pore inter-
connections are undoubtedly larger than a 100 μm. The brighter appearance of the 100 μm 
microspheres results from their size. The total volume of 10 000 microspheres of size 
100 μm is approximately 50 times the volume occupied by 60 000 microspheres of size 
15 μm. 
The Sc-COMP50 scaffolds were examined only using microspheres of size 100 μm. Be-
cause of the TCP particles disturbing the image, a similar 3D view from the side compared 
to the PLCL scaffolds was not meaningful. Figure 14 shows a representative sight into a 
crosscut of a Sc-COMP50 scaffold seeded with 10 000 microspheres. 
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Figure 14. A cross sectional image of an Sc-COMP50 scaffold seeded with 100 µm iron-
labeled microspheres. Some of these spheres can be seen in the pores at the cross section 
of the scaffold. Scale Bar 500 μm. 
There are clearly many particles on top of the scaffold, but some can be spotted also inside 
the structure in the pores. In the undermost quarter of the scaffold, only few particles were 
seen. 
6.2 Characterization of the hASCs 
0 lists the three cell lines used in this work as well as their expressions of different surface 
markers as analyzed by flow cytometry. The cell lines are named as human fat stem cells 
(HFSC) with a unique number indicating their isolation order and year. Cell line 3 was 
used with the third Sc-PLCL and Sc-COMP50 experiments, as well as with the PLDLA 
96/4 scaffolds. 
 
 
 
 
47 
Table 4. Surface marker expressions of different cell lines used in this study. The ASC 
criteria indicates the minimal requirements for adipose-derived stem cells as intro-
duced by the ISCT in (Dominici et al. 2006).   
Surface  
protein 
Cell line 1   
HFSC1/14 
(%) 
 
Cell line 2 
HFSC40/12 
(%) 
Cell line 3 
HFSC2/14        
(%) 
ASC  
criteria 
(2006) 
CD3 0.4 0.2 0.2  
CD11a 0.8 0.7 0.6  
CD14 0.7 0.8 0.3 ≤2% 
CD19 0.6 0.6 0.3 ≤2% 
CD34 9.7 48.5 35.4 ≤2% 
CD45 1.1 0.7 1.4 ≤2% 
CD54 2.8 32.2 6.6  
CD73 98.4 97 96.7 ≥95% 
CD80 0.6 0.8 0.4  
CD86 0.5 0.6 0.3  
CD90 99.6 99.7 99.7 ≥95% 
CD105 99.4 99.3 97.5 ≥95% 
HLA-DR 0.7 1.2 0.6 ≤2% 
 
According to the analysis, all the cell lines expressed the markers CD73, CD90 and 
CD105 strongly (≥95%). At the same time, the expression of the surface markers CD14, 
CD19, CD45 and HLA-DR is very weak (≤2%). All of these values are perfectly in line 
with the minimal criteria for adipose-derived stem cells, proposed by the ISCT (Dominici 
et al. 2006). However, contrariwise to the criteria, the hematopoietic marker CD34 shows 
moderate expression in all of the cell lines.  
6.3 Cell seeding results 
All the analyses were performed at a time point of 3 days. Before performing the experi-
ments, the well plates were always imaged using light microscopy to ensure there were 
no bacterial contaminations. The well plate images of the COMP50 scaffolds are pre-
sented in Appendix 1. Typically, a large amount of cells growing on the well were noticed 
in the case of scaffolds seeded with static and squeezing methods. The syringe methods 
resulted mainly in a low number of cells growing outside the scaffold. Black specks, in-
terpreted as dead cells, were seen in the case of squeezing and centrifugation methods. 
6.3.1 Cell viability and 2D distribution 
At a 3 day time point, cell viability and distribution in 2D were qualitatively analyzed 
using Live/Dead staining. Green fluorescence represents viable cells, whereas dead cells 
48 
are seen in red. Along with the top and bottom surfaces, the cross sections were imaged. 
Figure 15 illustrates the results from the third Sc-PLCL experiment. The results of the 
two previous experiments are shown in Appendix 2. 
 
Figure 15. Representative Live/Dead images from one of the three Live/Dead experi-
ments performed on Sc-PLCL scaffolds. Scale bars 500 μm. 
The syringe methods resulted in less cells on the top of the scaffold than the other seeding 
methods. In the cross sectional view, they also showed some cells in every depth from 
the bottom to the top. The statically seeded scaffold cross cut in Figure 15 also demon-
strated quite a lot of cells distributed relatively evenly - however from the two parallel 
samples, the other one performed significantly poorer. No significant differences were 
seen in the bottom surfaces. The other two experiments showed essentially similar results 
even in the case of the first experiments with only 60 000 seeded cells. Some dead cells 
were seen in the case of centrifuged scaffolds. Some individual large cell clusters were 
occasionally spotted on the bottom or in the middle of the cross section images of the 
statically seeded scaffolds. 
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Figure 16 presents the results of the third Sc-COMP50 experiment. The two other repeti-
tions are again available in Appendix 2. 
 
Figure 16. Representative Sc-COMP50 Live/Dead images. Scale bars 500 μm. 
The static, squeezing, centrifugation and injection methods result in a smooth cell sheet 
on the top surface of the scaffold. The scaffolds seeded with the syringe methods have 
again less cells on the top surface, but it can be seen that there are some cells at least 
inside the uppermost pores. The cross cut pictures show very few cells: the syringe meth-
ods have some individual small clusters in the middle of the scaffold. The clusters are 
typically yellowish due to part of the cells being viable and some already dead. Also the 
cross sectional view demonstrates how for example the static method has a lot of cells on 
the top, but not many deeper in the scaffold. Again the other experiments performed quite 
similarly. Some more clusters with dead and alive cells are seen in the cross section im-
ages. 
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The knitted PLDLA 96/4 scaffolds showed desirable results in terms of cell distribution 
and viability, as shown in Figure 17. Single dead cells were seen, but the absolute majority 
was viable. All the images including the cross sections indicated an even, relatively fre-
quent cell distribution regardless of the cell seeding method. 
 
Figure 17. Knitted PLDLA 96/4 scaffold Live/Dead images. Scale bars 500 μm. 
The non-woven PLDLA fabrics showed quite many dead cells, as seen in Figure 18. 
 
Figure 18. Cell viability in non-woven PLDLA 96/4 scaffolds. Scale bars 500 μm. 
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The actual number of dead cells was even higher, since some of the cells were stained 
only lightly and thus could not be included in the final images. Dead cells were found in 
all of the scaffolds regardless of the seeding method. The distribution of the cells however 
seems very even. The top and bottom surfaces show similar results between different 
seeding methods and there are adipose-derived stem cells in every depth of the cross sec-
tion. 
6.3.2 Quantitative cell number 
The amount of DNA in the scaffolds was quantitatively examined applying the 
CyQUANT analysis. The amount of DNA reflects the number of cells in the sample. The 
relative cell number results are presented in Figure 19 with respect to the static seeding 
method, which is considered to be the standard seeding method and is thus fixed into the 
value 1. Three experiments were performed with both of the ScCO2 processed scaf-
folds. The results of the missing two experiments are presented in Appendix 3.  
 
Figure 19. Relative CyQUANT results with respect to the static method, which is consid-
ered as the control sample. 
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The absolute results are presented in Figure 20, with again the remaining ScCO2 pro-
cessed scaffold experiments 1 & 2 attached to Appendix 3. 
 
Figure 20. Absolute CyQUANT results. The Y Axis shows fluorescence values resulting 
from the CyQUANT GR dye, which binds to cellular nucleic acids.  
The results concerning Sc-PLCL scaffolds showed different absolute results, but similar 
relationship between each cell seeding method. As the first experiment was done using 
60 000 adipose-derived stem cells per scaffold, 120 000 cells were used in the later sets. 
In the experiment 2 the scaffolds were also cut into 4 pieces to facilitate getting all the 
DNA material from inside the relatively dense scaffolds into the samples. Since the rela-
tive results did not change dramatically between these two experiments, the chopping step 
was left out from the last experiment. Comparing the second and the third experiment 
reveals, that there actually is a difference depending whether the scaffolds are chopped 
into pieces or not. Still, the relative results between different cell seeding methods remain 
unaffected. 
Clearly there were 3 methods (static, squeezing and centrifugation) that performed the 
best in this analysis regarding both ScCO2 processed scaffold types. Typically these re-
sults fit into the error margins of each other. This was also the case in Sc-COMP50 scaf-
folds, where the squeezing method seems to perform a bit worse at a first glance. The 
reason for this and to the relatively large error margin was the fact that in each of the 
experiments, one of the three squeezed scaffolds had a significantly lower result than the 
other two parallel samples. The injection method showed very variant results between 
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different repetitions, but ranked typically fourth in terms of cell number. The performance 
of the syringe methods was very poor with both Sc-PLCL and Sc-COMP50 scaffolds, 
especially in the case of COMP50. 
Both knitted and non-woven PLDLA 96/4 scaffolds showed similar results: the static and 
the squeezing methods ranked the highest with not much difference between each other. 
Compared to Sc-PLCL and Sc-COMP50 scaffolds, the centrifugation method performed 
significantly worse. The cell amount by injecting the cells ranked a bit lower than the two 
best methods. Again, both syringe methods performed the worst, still obtaining better 
absolute results than in the case of Sc-COMP50 scaffolds. 
6.3.3 Micro-CT & Prussian blue 
The novel combination of USPIO-labeled adipose-derived stem cells and micro-CT 
imaging was first tested by seeding 3 500 cells on a well plate. The result, shown in 
Figure 21, verifies that USPIO-labeled cells can be detected with micro-CT technology. 
Green roughness on the well piece denotes iron oxide particle clusters inside the cells. 
 
Figure 21. Micro-CT image of USPIO-labeled cells on a well plate. The green-colored 
signals are USPIO particles. Scale bar 250 μm.  
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Along with the succesful well plate test, the method was tested with a Sc-PLCL scaffold. 
The result is shown in Figure 22. 
 
Figure 22. Sc-PLCL scaffold with statically seeded USPIO-labeled ASCs at a time point 
of 1 day. Both images show the same scaffold, with the PLCL matrix being faded out on 
the right side. Scale bar 5.0 mm. 
When testing the visibility of the USPIO-labeled cells in Sc-COMP50 scaffolds, it 
became clear that the USPIOs cannot be distinguished from the scaffold. As seen in 
Figure 230 where the PLCL bulk has been faded out from the picture, the dense tricalcium 
phosphate granules dominate the image with their high intensity. 
 
Figure 23. β-TCP granules inside a COMP50 scaffold. The PLCL matrix has been faded 
out from the image. Scale bar 5.0 mm. 
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Detecting the nanoparticle clusters from polymeric scaffolds was easier. Figure 24 shows 
Sc-PLCL scaffolds seeded with different methods. The other two experiments are 
presented in Appendix 4. The scaffolds are gradually faded away from the pictures: the 
piles on the left show the polymer, whereas on the right only the USPIO nanoparticles are 
seen. 
When looking the pictures closely, there were USPIO nanoparticles in the middle of the 
scaffold to some extent in almost every scaffold - only the injection method showed poor 
results. In the experiment 2 (Appendix 5), all the other methods performed equally well. 
Still, when evaluating the 3 experiments as a whole, the Syringe 1 method resulted in best 
results when it comes to the 3D distribution of the cells. Because of this, Figure 24 was 
considered to be a good representative of all the experiments. 
The prussian blue results from all of the experiments are presented in Appendix 5. Any 
iron in the samples is colored in blue. The cytoplasm shows pink and the nuclei bright 
red. Based on the Prussian blue images, the USPIO-labeling in Sc-PLCL experiment 2 
had succeeded somewhat better than in the other repetitions. The appearance of the 
USPIO-labeled cells used with the knitted and non-woven PLDLA 96/4 scaffolds showed 
an unusual appearance. Still, blue iron could be seen in the Prussian blue images. 
 
Figure 24. Scaffolds seeded by different cell seeding methods. The three piles represent 
same scaffolds with different kind of image processing. The first pile from the left shows 
the scaffold - from the second pile some nanoparticles can be detected inside the scaffold 
that is faded. In the last pile, the scaffold material has been completely faded away with 
only USPIO particle signals left in the image. Scale bar 5.0 mm.  
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The micro-CT results of the knitted PLDLA scaffolds were controversial to those ob-
tained with the Live/Dead staining: only very few, if any, USPIO-labeled cells are seen. 
Figure 25 illustrates the situation. 
 
Figure 25. Micro-CT images of the knitted PLDLA scaffolds seeded with USPIO-labeled 
cells. Again, the scaffold piles on the left show the scaffold only, whereas the piles on the 
right are processed to show only USPIO particle signals. In the middle, only part of the 
scaffold has been faded away with some visible signals from the USPIO particles as well. 
In the statically and centrifugally seeded scaffolds, the seams obtained by heat sealing 
are seen. Scale bar 5.0 mm. 
In the case of non-woven PLDLA fabrics, some USPIO-labeled cells were detected. Also 
the variation in scaffold heights becomes clear when looking at the Figure 26. Both sy-
ringe methods show an even yet relatively loose 3D cell distribution, but the comparison 
of the methods is very difficult due to the differences in the scaffolds. The statically 
seeded scaffold also contains some USPIO particles, but not much is seen in the scaffolds 
seeded with centrifugation, squeezing or injection methods. These three scaffolds were 
also significantly thinner than the rest. 
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Figure 26. Non-woven PLDLA 96/4 fabrics as imaged with micro-CT technology. Para-
film sheets used to hold the sample still during the imaging process can be seen on the 
left pile. The scaffold material has partly been faded away to show some signals from the 
USPIO-labeled cells as well. On the right, only USPIO particle signals are seen. Scale 
bar 5.0 mm. 
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7. DISCUSSION 
Successful cell seeding enables uniform ECM deposition and tissue growth throughout 
the engineered construct. In the case of non-uniform seeding, unwanted nutrient and me-
tabolite gradients are formed around the scaffold. (Bueno et al. 2007) When choosing for 
a suitable cell seeding method, the effect of the cell type, scaffold structure and material 
need to be taken into account. In an ideal case the method is also simple, fast and repro-
ducible (Soletti et al. 2006). The more additional equipment and scaffold handling the 
cell seeding method requires, the bigger is also the contamination risk. 
7.1 Scaffold properties and microsphere cell seeding model 
In this study, 4 different scaffold types were used. Sc-PLCL and Sc-COMP50 scaffolds 
were made with supercritical carbon dioxide processing, whereas knitted PLDLA and 
non-woven PLDLA scaffolds were produced from different PLDLA 96/4 fibers by ap-
plying knitting and non-woven technologies, respectively. The Sc-PLCL and 
Sc-COMP50 scaffold types had similar porosities of 65%, as analyzed from the micro-CT 
data. However, micro-CT image analysis showed that the COMP50 scaffolds had smaller 
pore sizes. 
One challenge in these scaffolds is that the micro-CT analysis does not take a stance on 
the shape of the pores or their interconnectivity, which is difficult to determine because 
of the limitations in the micro-CT resolution. If the wall thickness or a pore is smaller 
than the micro-CT can identify, the result of the analysis is misleading (Darling & Sun 
2004). Partly for this reason, the microsphere seeding tests were performed. The results 
are however not directly comparable with each other: the 15 µm microspheres occupied 
a 50 times lower volume compared to the 100 µm particles. Thus, the larger particles can 
be seen to a larger extent in the images. Also the field of view is smaller in the image of 
Sc-PLCL scaffold seeded with 15 µm particles (only part of the scaffold is shown). Due 
to the dense β-TCP particles and their strong signals in the micro-CT images, a compara-
ble 3D view of the COMP50 scaffolds was not reasonable. This not only makes the com-
parison between these two scaffold types difficult, but also complicates the objective 
evaluation of the particle distribution inside the COMP50 scaffolds, since only a single 
crosscut image at a time can be evaluated. 
Based on the microsphere analysis, the interconnectivity of the Sc-PLCL scaffold pores 
was high. Even with static seeding only, there were microspheres in every depth of the 
scaffold. The reason for the lower 100 µm particle frequency on the sides probably re-
sulted from the seeding method: pipetting suspension drops to the absolute periphery of 
the scaffolds without wasting microspheres was challenging. The particle distribution is 
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more difficult to evaluate with the COMP50 scaffolds, but it was noticed that there were 
only few 100 µm microspheres in the undermost third of the scaffold. Another finding 
was that there were multiple pores so small, that only one microsphere fit the pore. This 
result was consistent with the micro-CT analysis, which demonstrated smaller pore size 
of Sc-COMP50 scaffolds compared to the Sc-PLCL scaffolds.   
Besides the interconnectivity analysis, another interesting but tricky question regarding 
microsphere seeding is whether or not they can be used to model actual cell seeding. The 
microspheres sediment so quickly in both PBS and distilled water, that their behavior can 
be expected to be dominated by gravity in the scaffolds as well. This is not always the 
case with living cells (Ghavidel Mehr et al. 2014). Another crucial difference between 
the microsphere and cell seeding experiments is the fact that the microspheres are not 
attached or fixed to the scaffold. This might permit their movement deeper into the scaf-
fold during the drying phase, as the water in the pores evaporates. Also the spherical shape 
of the microspheres might facilitate their infiltration deeper into the scaffold compared to 
the cells. 
Another group has performed similar tests with 10 µm polystyrene microspheres imaged 
with phase contrast microscopy: they concluded that the microspheres provide a baseline 
for non-aggregated, trypsinized cell seeding, but it must be remembered that cells do not 
always behave as single entities (Ghavidel Mehr et al. 2014). Indeed, one concern about 
cell seeding of Sc-COMP50 scaffolds was, whether the cells permeate to the inner pores 
of the scaffold or aggregate rather on the surface. Cell aggregates might prevent nutrient 
transport or cell infiltration into the scaffold (Ding et al. 2008; Ghavidel Mehr et al. 2014).  
According to the hypothesis that cell seeding could be modeled with iron-labeled micro-
spheres, the microsphere results promise easy seedability of the PLCL scaffolds with 
hASCs as well. For evaluating the 3D cell distribution in cell seeding, a novel method 
was proposed utilizing USPIO-labeled hASCs and micro-CT technology. Previously, ul-
trasmall iron oxide nanoparticles have mostly been used as contrast agents in magnetic 
resonance imaging both in vivo and in vitro (Oude Engberink et al. 2007; Mathiasen et al. 
2013; Weissleder et al. 1995). When comparing the microsphere results to the statically 
seeded USPIO-labeled cell images, a lot of similarities were seen. Especially in the pre-
liminary cell test after 1 day, cells are seen quite evenly distributed in the scaffold. This 
is also the case with the 3-day experiments, although the amount and intensity of the 
signals is lower. Both microsphere sizes show signals in the scaffold in an even more 
comprehensive manner, which is intuitively understandable since the amount of iron is 
higher in the microspheres and not all of the cells are successfully USPIO-labeled.  
As a result, in the case of Sc-PLCL scaffolds the iron-labeled microspheres imply better 
seeding results than can be produced with the USPIO-labeling method. Keeping in mind 
the seemingly better tendency of microspheres to infiltrate into the scaffold pores and 
especially their better visibility in the micro-CT images, it appears that the microparticles 
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offer a functional way to model cell seeding in this type of scaffolds. The situation might 
be different with Sc-COMP50 scaffolds. As already discussed, the 100 µm microspheres 
did not occupy the COMP50 scaffolds as evenly as they did with PLCL scaffolds. The 
lack of an adequate 3D imaging method for composite scaffolds makes it challenging to 
compare the cell distribution to that of the microspheres. Still, the 2D Live/Dead images 
of the cells indicate again a worse distribution compared to the microspheres: a sheet of 
cells can be seen on the top of many scaffolds. As a conclusion, the microspheres are 
potential candidates for providing an excellent model of the interconnectivity and seed-
ability of the ScCO2 processed scaffolds, but caution must be obeyed when the results are 
used to model cell seeding results (Ghavidel Mehr et al. 2014). 
Naturally the material properties also have an impact on the scaffold properties. When 
comparing the two ScCO2 processed scaffold types, the COMP50 scaffolds are under-
standably more rigid, yet they still show an elastic and ductile behavior. The embedded 
β-TCP granules increase their hydrophilicity compared to the hydrophobic Sc-PLCL scaf-
folds. (Ahola et al. 2012) When the scaffolds are cut into their final dimensions, it is done 
with a scalpel by hand, leading to variations in the scaffold heights. In cell seeding, this 
can have an impact on the final outcome (Bryant & Anseth 2001). Cutting the COMP50 
scaffolds might also reveal more surface area of bioactive β-TCP on the cut surface, which 
might attract the cells and thus reduce their migration willingness deeper into the scaffold.  
Despite the hydrophobicity of polylactide, both knitted and non-woven PLDLA scaffolds 
sunk effortlessly to the bottom of the falcon tube in the pre-wetting phase, which clearly 
addresses their loose structure. The knitted scaffolds varied a lot in height depending on 
the width of the knit. Also the non-woven fabric was patchy resulting in significant height 
variations of the non-woven scaffolds. It also needs to be taken into account, that the 
height measurements were done dry and the dimensions of the non-woven scaffolds 
change when wetted. 
7.2 Stem cells and cell culturing 
Characterization of the adipose-derived stem cells showed the mesenchymal origin of the 
cell lines used in the experiments. Only the hematopoietic surface marker CD34 showed 
higher expression values than suggested in the ISCT criteria for adipose-derived stem 
cells, which is typical when human serum is included in the culturing media. The expres-
sion of this marker is shared by endothelial cells and hematopoietic stem cells (Bourin et 
al. 2013). Since the absolute majority (99%) of the hematopoietic cells should not adhere 
to cell culturing dishes (Gordon et al. 2006) and the endothelial cells in general are very 
dependent on shear stress and supplements, they may dedifferentiate or trigger apoptosis 
when cultured statically (Baer & Geiger 2012). Since the analyzed cells were at passage 1, 
it can be assumed that the expression of CD34 would decrease along passaging. 
61 
The 3 different cell lines showed distinct proliferative properties. Cell line 1 proliferated 
particularly fast - the cells started readily to curl on top of each other and the flasks were 
confluent only a few days after passaging. Cell line 2 had a moderate cell proliferation 
rate. The third cell line, used for the third set of ScCO2 processed scaffold experiments 
and for the PLDLA 96/4 scaffolds, showed quite fast proliferation, although not as active 
as the first cell line. These differences might affect the results of the cell number analysis 
and the efficiency of the USPIO-labeling, as the iron oxide particles become diluted 
(Küstermann et al. 2008). 
7.3 Cell seeding methods 
The study was based around 6 different cell seeding methods. Out of these, the static 
method was considered to be the standard control method due to its easiness and sim-
plicity (Dai et al. 2009; Vitacolonna et al. 2013). In this method, no external forces are 
applied to the cells, which in some cases leads to non-uniform cell distribution (Ding et 
al. 2008). However, it also means that the cells are not subjected to forces that could 
possibly alter their viability or function. A uniform distribution of cells using static seed-
ing requires a loose enough scaffold structure to enable cell migration and passive diffu-
sion of cells into the scaffold. Another advantage of the method is that it is not dependent 
on the scaffold type. 
The squeezing method was hypothesized to lead to better seeding results by means of 
suction forces created by squeezing the elastic ScCO2 processed scaffolds. Squeezing be-
fore the cells were applied clearly had an effect on these scaffolds: especially the 
Sc-COMP50 scaffolds felt hard at the beginning despite the pre-wetting at +37ºC. After 
the pre-squeezing, the scaffolds were softer and more elastic. In addition to the sectional 
forces, it was postulated that the inner microstructure of the scaffolds might get broken 
during the pre-squeezing, which could result in an even better interconnectivity of the 
pores. The squeezing method was also applied to the knitted and non-woven PLDLA 96/4 
scaffolds, but the knitted scaffolds could not be squeezed much without breaking the scaf-
fold structure. Even low force squeezing resulted in deformation of the scaffold shape. 
As expected, the non-woven scaffolds recovered poorly from the stress.  
One concern with the squeezing method was the usage of the sterile plastic pouches. Han-
dling and orienting the scaffold in a desired way was often complicated due to the slippery 
pouch. Touching the sides of the pouch with the top side of the scaffold (where the cells 
were seeded) was tried to be avoided, often unsuccessfully. This, as well as the flow of 
medium and cell suspension from the scaffold during the squeezing process admittedly 
led to losing some of the cells to the pouch during the seeding process. 
One of the methods with a significantly larger cell suspension volume was centrifuga-
tion. The way it was done in this work is partially dependent on the scaffold shape and 
mechanical properties. Soft non-woven fabrics and knitted scaffolds seemed to detach 
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from the bottom of the falcon tube. At the same time, pressing the scaffolds too tightly 
needs to be avoided or the openness of the pores might be compromised. Some minor 
problems were related in removing the scaffold from the tube – caution was needed to 
avoid contaminations and to keep track which was the top side where the cells were 
seeded. One question regarding this method is associated with the hypothesized fluid flow 
through the scaffold: of the cell suspension volume, how much actually flows through the 
pores and what portion goes directly to the bottom of the falcon tube from the sides? To 
avoid wasting cells, it is possible to re-suspend the cells from the bottom of the tube be-
tween centrifugation (Roh et al. 2007), but this makes the process also more time-con-
suming and complicated. 
Similar problems with the fluid flow were encountered with both of the syringe methods. 
Before starting the cell seeding experiments, the methods were tried out with distilled 
water and Sc-COMP50 scaffolds. These scaffolds fit the syringes tightly enough to pre-
vent the liquid from flowing past the scaffold before applying pressure with the syringe 
plunger. Later it was noticed that this was not the case with the other scaffold types, or 
even with some of the COMP50 scaffolds. Instead, the cell suspension flowed often freely 
past the scaffold. Also the COMP50 scaffolds fitting the syringe tightly raised a question 
whether the fluid actually flows through the scaffold - some signs were noticed that at 
least part of it slips past the scaffold. Ideally, this should be prevented by tight-fitting the 
scaffold into the syringe, yet leaving the porous structure open for fluid flow. 
Concerning syringe 1 cell seeding method, the looseness of the scaffold-syringe con-
struct meant that most of the 1 ml cell suspension had already flown out from the syringe 
before the plunger was used. The effect of the pressure created by the plunger was anyhow 
clearly seen, as the remaining cell suspension splashed forcefully out from the syringe. 
At the same time, the appearance of the more loosely structured pre-wetted knit and non-
woven scaffolds turned paler and drier, due to the cell culturing media partly escaping the 
scaffold.  
The larger cell suspension volume means that a large amount of cells are wasted with the 
excess cell suspension. The rationale behind it was to create fluid flow inside the pore 
network of the scaffolds and to avoid too high cell densities in the suspension, which 
might result in aggregates on top of the scaffold. In syringe 2 method, the idea was to 
actualize the fluid flow from both sides of the scaffold. With most of the scaffolds, the 
tightness of the construct was not sufficient. In practice, this meant that the seeding 
method turned out to be a semi-static seeding method: the scaffolds floated in cell sus-
pension as the syringe constructs were handled according to the protocol. 
Out of these 6 seeding methods, the injection method was probably the most dissatisfy-
ing in terms of repeatability. First of all, the injection depth needed to be estimated in 
every injection. Pushing the needle too far resulted in injecting most of the cell suspension 
directly to the bottom of the well. Another concern was dividing the cell suspension 
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evenly into the 5 injection spots.  Not only estimating such small volumes was hard, but 
achieving the even division in practice required extreme precision. In addition, the 
method damages the scaffold structure slightly. In the case of Sc-COMP50 scaffolds, dark 
traces of metal particles were left to the injection sites, indicating that the needle is ground 
by the ceramic content. 
7.4 Cell viability and 2D distribution analysis 
Live/Dead staining was used as a qualitative method to assess the viability and distribu-
tion of the cells seeded into the scaffolds. Some caution must be kept in mind when in-
terpreting the results, as there are a few concerns related to the method. Although the 
washing steps and staining were performed very carefully, it is possible that the dead cells 
might be washed away. The two-dimensional nature of the analysis is an even bigger 
limitation, leading easily to misinterpretations. It is also questionable whether the dyes 
diffuse into the center of the scaffold: there were some lightly colored cells to be seen 
with the microscope, but the staining was not strong enough to be shown in the final 
images. Moreover, one reason for the better-looking crosscuts of the PLCL scaffold is 
due the transparency of the polymeric material. Some viable cells can be seen in the PLCL 
scaffolds although the cells were a bit deeper in the material. The composite material 
lacks this feature and practically shows only the cells on the same plane. 
The experiment series was started with seeding 60 000 cells per Sc-PLCL scaffold. The 
Live/Dead results for this experiment 1 showed only a moderate amount of cells on the 
scaffold crosscut images, which were used to evaluate the distribution of the cells. Still, 
as discussed it needs to be remembered that these images represent only a 2D vision. Both 
syringe 1 and syringe 2 methods along with centrifugation showed the best results in 
terms of obtaining the most cells on the plane of the crosscut. Perhaps even more im-
portantly, these methods seemed to result in cells locating from the top to the bottom of 
the scaffold. On the other hand, the possibility that some of the cells have been transferred 
from the top surface via the scalpel needs to be taken into account. A low number of dead 
cells were seen in the scaffold seeded by centrifugation and some individual ones in other 
scaffolds.  
With the aim of seeing more cells on the crosscuts, the amount of cells seeded was dou-
bled after the first experiment. Contradictory, the Sc-PLCL Live/Dead experiment 2 re-
vealed qualitatively evaluated even less cells on the crosscut images. Only the syringe 1 
method seemed to perform better. In this experiment, the centrifuged scaffold has possi-
bly flipped during its removal from the falcon tube, showing more cells on the bottom 
than on the top of the scaffold. The third experiment showed more cells, with all of the 
methods performing in a tolerable manner. In all of the experiments, static, squeezing and 
centrifugation methods resulted in aggregates being formed on the top surface of the scaf-
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fold, denoting a better seeding efficiency and possibly the fact that most of the cells re-
main on the top surface after seeding. As expected, the injection method demonstrated 
very varying results. 
All the 3 experiments performed with the Sc-COMP50 scaffolds showed quite similar 
results with each other, with hardly any cells on the crosscut images. The static and cen-
trifugation seeding methods as well as partly the squeezing method all lead to a smooth 
sheet of cells on top of the scaffold. On one side the smoothness of the sheet implies that 
the material is more desirable to the cells. On the other side, combined with the crosscut 
image results it suggests that these methods might be unable to seed the cells deeper into 
the scaffold. This is probably partly attributed to the smaller pores of the COMP50 scaf-
folds. The top surface images of the squeezing method together with the syringe methods 
showed clearly living cells inside the outermost pores, which is a good sign but does not 
justify any definite conclusions about their functionality. All in all, the syringe 1 method 
would be suggested based on the Live/Dead results, but no definitive conclusions should 
be made from these 2D pictures. 
The viability of the cells on the ScCO2 scaffolds was on a very good level with only few 
dead cells. This demonstrates the cytocompatibility of the material. The few dead cell 
aggregates found from the middle of some scaffolds probably result from poor turnover 
of nutrients and metabolic products. This could probably be improved with bioreactor 
culturing (Martin et al. 2004). Slow diffusion of culturing media would also support the 
assumption of imperfect penetration of the dyes into the center of the scaffold. 
Owing to their loose structure, the knitted PLDLA 96/4 scaffolds proved an extremely 
good seedability with any of the 6 cell seeding methods. The amount of dead cells was 
again low. Also in the center of the scaffold, only few dead cells were noticed, probably 
due to the accessibility of cell culturing media inside the scaffold caused by the loose 
structure. As a conclusion, all of the tested methods are suitable for seeding these scaf-
folds. Thus, the static method is recommended due to its simplicity and rapidity (Vitacol-
onna et al. 2013). Correspondingly, the squeezing method is not suggested because of the 
scaffold deformation and damage risk.  
The non-woven PLDLA 96/4 fabric scaffolds demonstrated also very good seedability. 
The top and bottom surfaces both had living cells attached regardless of the cell seeding 
method. Also the crosscut images proved that there are cells throughout the whole height 
of the scaffold. However, the non-woven scaffolds also showed a significantly higher 
number of dead cells than the other scaffold types. Even more lightly colored dead cells 
were seen at the fluorescence microscope, but not all could be displayed in the final 
Live/Dead images. Since the raw material and the cell line were the same than those used 
with the knitted scaffolds, the most probable reason lies in the structure of the scaffold. 
The PLDLA fiber diameter in the non-wovens was more than 5 times lower compared to 
the 4-filament fibers used to produce the knit. Most probably the small fiber diameter has 
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caused problems in the attachment of the relatively large hASCs, which is also supported 
by the spherical shape of the cells (Karageorgiou & Kaplan 2005). On the other hand, the 
closed scaffold structure makes it also more difficult for the dead cells to shed from the 
scaffold during the staining process, leading to their visibility in the images. 
In addition to the actual analyses, the well plates were always light microscopy imaged 
at the time point of 3 days before performing the analyses. This was done to ensure that 
there were no bacterial contaminations and to evaluate the amount of cells growing out 
from the scaffolds. Those wells with scaffolds seeded using the centrifugation and 
squeezing methods contained black specks, which were interpreted to be dead cells. It 
was thus concluded that these methods are the most stressful ones for the cells. The effect 
was especially clear with the Sc-COMP50 scaffolds (Appendix 1). Previously, a small 
decrease in cell viability as a result of increased cycles of squeeze-loading has been re-
ported (Xie et al. 2006). Also the individual dead cells in the Live/Dead images favor this 
theory.  
7.5 Cell number analysis 
The cell number analysis was done quantitatively. The utilized CyQUANT analysis how-
ever does not take any stance on the distribution of the cells, which is a very important 
measure when evaluating the success of cell seeding. Another concern is whether all the 
DNA from inside the scaffold can be included into the analysis. Accordingly, using 
CyQUANT only is not a sufficient measure for evaluating cell seeding. It provides any-
how useful, quantified and accurate information about the cell number in different sam-
ples. The amounts of DNA presented in this work result not only from initial cell attach-
ment, but also from 3 days of cell proliferation, which should be noted (Vunjak-Nova-
kovic et al. 1998). 
The CyQUANT analysis performed on dense 3D scaffolds is assumed to favor cell seed-
ing methods that seed the cells on top of the scaffold. Firstly, the cells on the top surface 
have a better access to the nutrients in the cell culturing medium compared to those deeper 
in the scaffold. Thus, the cells on the scaffold periphery can be expected to proliferate 
faster (Bueno et al. 2007). Secondly, the question about getting all the DNA material deep 
from the scaffold is valid, despite the fact that the detergent solution is pipetted quite 
forcefully from both sides of the scaffolds when collecting the sample. If there are prob-
lems getting the cell suspension into the pores, it should also be challenging to pipette the 
detergent solution into the pores (and getting it out from there). This assumption is sup-
ported by the observations of lightly colored cells in the Live/Dead analysis: the dyes 
probably did not diffuse into some scaffold types in adequate amounts. 
In all of the 3 CyQUANT experiments performed with the Sc-PLCL scaffolds, there were 
three seeding methods, namely static, squeezing and centrifugation methods that resulted 
in higher amount of cells compared to the other methods. The most important reason for 
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the success of static and squeezing methods in cell numbers is probably related to the 
amount of wasted cells. A cell suspension volume of 50 μl can be effectively seeded to 
the scaffold with a great number of cells being offered a realistic chance to attach to the 
scaffold. On the contrary, the cell suspension volume of 1000 μl in centrifugation and 
both syringe methods inevitably led to most of the cell suspension ending up as wasted 
material. In this respect, the great cell numbers in centrifugally seeded scaffolds might 
seem odd at first. Conversely, the centrifugal forces undoubtedly separate the cells from 
the medium by pressing them down. Intuitively it thus makes sense that a lot of cells end 
up in contact with the scaffold. Previous experiments have also shown increased cell at-
tachment when applying centrifugation (Roh et al. 2007) In the case of the syringe seed-
ing methods, not even the bigger scaffold volume and surface area facilitated adequate 
cell numbers. 
The Live/Dead images showed repeatedly, that the top three methods (static, squeezing, 
centrifugation) result in a large number of cells on the top surface of the scaffold. This is 
one factor supporting their success in CyQUANT analysis. The injection method showed 
relatively versatile results throughout the experiments. This is undoubtedly related to the 
challenges in repeatability of the method. The relatively low volume of 110 μl ensures 
that at least a moderate amount of cells can always be brought in good contact with the 
scaffold. On the other hand, some of the cells were always lost into the syringe and when 
part of the injected cell suspension spilled out from the scaffold. When pressing the needle 
too deep, most of the suspension had the chance to flow directly to the bottom of the well. 
As the scaffolds were always transferred to clean wells after seeding (and after 3 days 
before collecting the CyQUANT samples), this has an impact on the cell number. 
The same static, squeezing and centrifugation methods generated the best results also in 
Sc-COMP50 scaffolds. In addition, the injection method stood up to the same group in 
two out of three experiments, but again showed variant results due to the low repeatability 
of the method. The seemingly varying results of the squeezing method can be explained 
by the challenging handling of the scaffold inside the squeezing pouch: in some cases 
more cells are simply lost to the slippery pouch as the scaffold often twirls inside the 
pouch. The scaffold top surfaces in the Live/Dead images support these results, as static 
and centrifugation seeding lead to a smooth sheet of cells. In COMP50 experiments 1 and 
2, the squeezing method lacks the sheet, which might indicate more lost cells or a more 
even cell distribution with cells ending up deeper into the scaffold. 
When comparing any of the experiments performed with COMP50 scaffolds to the PLCL 
experiment 3 (PLCL experiments 1 and 2 were differently executed), the absolute cell 
amounts of the static and centrifugation methods are generally higher in the COMP50 
scaffolds. Not only the Live/Dead images from the top of the scaffold show the cell sheet, 
but also the crosscut images imply that these methods seed most of the cells to the top in 
COMP50 scaffolds. In addition, bioactive TCP granules are better exposed when the scaf-
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folds are cut into shape, which might accelerate cell proliferation and slow down the mi-
gration of the cells deeper into the scaffold. These cell number and 2D distribution results 
together address the better material properties but harder seedability of COMP50 scaf-
folds compared to the PLCL scaffolds. 
The syringe methods show practically negligible cell amounts. The presumably smaller 
pores of the COMP50 scaffold could lead to increased flow resistance in the scaffold, and 
thus result in most of the cell suspension slipping past the scaffold. Also the probability 
of DNA remaining in the scaffold instead of being included into the Triton samples rises 
as the scaffold porosity decreases. Since its effect on the results was seen with the PLCL 
scaffolds, cutting the COMP50 scaffolds into 4 pieces when collecting the samples could 
provide useful data about the supposed cell distribution as well. Comparing the results 
between the two ScCO2 processed scaffold types could reveal differences between the 
amounts of cells inside the two scaffold types. 
The cell numbers of knitted and non-woven scaffolds were quite similar with each other. 
On the other hand the looser structure of the scaffolds enabled a more reliable analysis by 
making it possible to collect most of the cells into the samples. Then again, it also allows 
some of the cells to flow through the scaffold to the well plate bottom. This is seen espe-
cially in the case of knitted scaffolds seeded with static and squeezing methods: the well 
plate images show dense cell clusters curled on top of each other on the wells. The flow 
through the scaffold is probably also the reason why the absolute cell amount on knitted 
PLDLA scaffolds was not superior compared to the non-woven scaffolds, despite the 
larger number of cells seeded. The syringe methods again lead to a low number of cells 
due to many cells being flushed away with the excessive cell suspension. Also the cen-
trifugation method led to a similar outcome with these scaffold types, because the scaf-
folds did not tightly fit the falcon tube. Thus, compared with the ScCO2 processed scaf-
folds, a bigger portion of the centrifuged cells ended up to the bottom of the tube.  
7.6 USPIO-labelled cells and the 3D distribution 
Although still a great indicator for 3D cell distribution inside scaffolds, the novel method 
of detecting cells inside a scaffold using USPIO-labeled adipose-derived stem cells and 
micro-CT imaging technology has some concerns that need to be considered when inter-
preting the results. First of all, not all cells take USPIO particles inside, and as the cells 
proliferate, the concentration of these cells increases. At the same time, proliferation of 
the successfully labeled cells dilutes the USPIO nanoparticle concentration inside these 
cells as mentioned before. This is insignificant up to a certain threshold level, where the 
cells contain enough iron oxide nanoparticles to be visible within the given resolution. 
The resolution of the micro-CT sets also other limitations: single nanoparticles cannot be 
detected, and on the other hand it is impossible to say how many cells are located on each 
spot with a visible signal. Similar challenges have been reported when imaging bony 
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fragments with sizes close to the resolution. (Petrie Aronin et al. 2009; Küstermann et al. 
2008) 
The method is also applicable only with scaffold materials that are not too dense (Ho & 
Hutmacher 2006) to disturb the signal of the USPIO nanoparticles. In the preliminary 
tests where individual COMP50 scaffolds were imaged, it was soon noticed that the signal 
intensity of the TCP granules was much stronger than that of the USPIO particles. Be-
cause of this, the COMP50 scaffolds needed to be excluded from the micro-CT experi-
ments. Since the Live/Dead staining provides only results of the 2D distribution with 
controversies as described earlier, an imaging method for evaluating the 3D cell distribu-
tion would be necessary. Meanwhile, iron-labeled microspheres can be used to give prac-
tical support to the micro-CT scaffold analysis, which gives accurate quantitative infor-
mation about the scaffold porosity. It is also hypothesized, that when the structure of the 
Sc-COMP50 scaffolds can be brought to the same level with the Sc-PLCL scaffolds, also 
the cell seeding results should be comparable. 
As explained in the results section, all the seeding methods besides the injection methods 
showed, to some extent, evenly distributed cells in the Sc-PLCL scaffold micro-CT im-
ages. Still, the syringe methods had the best performance in this regard. Out of the 3 
experiments performed, the USPIO labeling was done a bit differently in the first one. As 
the amount of USPIO particles was based on the original amount of cells seeded to the 
cell culturing flask and the particular cell line was extremely proliferative, the concentra-
tion of well labeled cells in the scaffolds was lower than in the other experiments, which 
shows in the Prussian blue staining (Roeder et al. 2014). This explains the relatively low 
intensities and seemingly low amount of signals from inside the scaffolds.  
The experiment 1 is still in line with the experiment 3, as the syringe methods showed the 
biggest amount of nanoparticle-based signals, but also centrifugation, squeezing and 
static methods had even cell distributions. In the experiment 3, syringe 1 method stood 
out from the rest. The cell line used in the third experiment was also fast proliferating. 
The experiment 2 was a bit different showing a very good result in most of the scaffolds. 
Prussian blue of the second experiment proved that the labeling was successful, which 
probably was one reason for the better-looking results compared to the other experiments. 
Again, the cell line could be a reason to this, as it proliferated slower than those used in 
the other experiments. 
It needs to be remembered that all the analyses are done at an early time point of 3 days. 
Depending on the end application, it should be evaluated whether the easiest static seed-
ing method provides starting conditions good enough for the development of functional 
tissue. In any case, the cell distribution inside the Sc-PLCL scaffolds can be improved by 
forcing the cell suspension to flow deeper into the scaffold by applying a syringe. Out of 
the two syringe methods, the simpler one where the syringe plunger is pushed only once 
is recommended due to its easier and faster use and slightly better results.  
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In addition to the micro-CT results, also the Live/Dead images show even distribution of 
the cells when using the syringe 1 seeding method. The cell numbers using this method, 
as obtained by the CyQUANT analysis, show poor results. It would be interesting to see 
if the cell numbers and perhaps also the 3D distribution as well could be improved by 
reducing the cell suspension volume - that is, by combining the static and syringe 1 meth-
ods. Even though most of the 1000 µl cell suspension goes to waste in the syringe meth-
ods, it is also possible that the small cell suspension volumes such as 50 µl simply lead 
to aggregates on top of the pores (Ding et al. 2008). Even if that was the case, it is possible 
that the pressure created in the syringe 1 method could break the aggregates. Decreasing 
cell suspension volume could lead to even better results, less wasted valuable cells and 
improved user-friendliness.  
The micro-CT results of the knitted PLDLA scaffolds were unexpected: hardly any US-
PIO-based signals were seen in the images. This contradicts the Live/Dead results nota-
bly, as in the Live/Dead analysis all the scaffolds proved to have a respectable amount of 
viable cells inside of them. When looking at the Prussian blue staining images, it can be 
seen that the cells look unusual compared to the others. The USPIO-labeling itself seems 
to be successful, as there is blue colored iron inside the cells and the micro-CT images of 
the non-woven scaffolds show clear signals from inside some scaffolds. Still, the fixed 
cells in the Prussian blue images seem to be struggling - for one reason or another they 
have probably detached from the scaffolds.  
Cells from the same batch were used with both of the PLDLA scaffold types. The same 
cell line was successfully used with the ScCO2 processed scaffolds. As the USPIO label-
ing of the cells was performed with one exception compared to the Sc-PLCL experiments 
2 and 3, this exception could also be the reason for the unexpected Prussian blue images. 
A non-sterile coverslip was used, after it was sterilized using 70% ethanol in the laminar 
hood. It is thus possible, that some ethanol residues have been left to the coverslip despite 
letting it dry before usage. This might have caused the changes in cell morphology. No 
contaminations or any other unusual occurrences were seen with light microscopy when 
visualizing the samples. 
70 
8. CONCLUSIONS 
The aim of this work was to find an optimized cell seeding method for different biode-
gradable polymer-based scaffolds using adipose-derived stem cells. In addition to the two 
ScCO2 processed scaffold types manufactured with supercritical carbon dioxide technol-
ogy from poly(L-lactide-co-ε-caprolactone) and its β-tricalcium phosphate composite, 
two other types, namely knitted and non-woven scaffolds made from polylactide fibers 
were experimented. 
With the aid of iron-labeled microspheres and micro-computed tomography imaging, the 
interconnectivity of the copolymeric Sc-PLCL scaffolds was first shown. The method 
was concluded to be a great tool for analyzing the seedability of ScCO2 processed scaf-
folds. The study also revealed that the cell distribution inside the PLCL scaffolds can be 
improved by forcing the cell suspension deeper into the pores using a simple syringe 
method. However, a large number of cells are wasted if this method is applied as such. 
The 3D distribution of the cells inside the scaffold was evaluated using a novel method 
where ASCs labeled with iron oxide nanoparticles were detected by micro-CT. 
The ceramic content of the composite scaffolds hindered micro-CT imaging in such an 
extent that determining the USPIO-labeled cells in the scaffolds was not feasible. The 
results related to cell number and viability as well as non-sterile microsphere seeding 
showed indications of possibly lower pore size or interconnectivity and thus harder seed-
ability compared to the Sc-PLCL scaffolds. Still, without a functional 3D imaging method 
no definitive conclusions should be made. Due to their loose structure, both non-woven 
and knitted polylactide scaffolds proved to be very seedable even with the standard static 
seeding method. The non-woven PLDLA scaffolds showed a relatively high number of 
non-viable cells, which raised a question about a too small fiber diameter. 
The study suggests a simple method using a syringe to seed cells more evenly into ScCO2 
processed scaffolds. With certain scaffold materials, a 3D imaging method applying US-
PIO-labeled cells and micro-CT can be used for cell distribution evaluation. Although the 
Sc-COMP50 scaffolds require a 3D imaging method to estimate cell distribution in the 
scaffolds, it seems that their pore sizes are smaller than those of the PLCL scaffolds. The 
knitted joint scaffolds admittedly have a functional structure in terms of cell seeding, but 
further studies are needed to optimize and evaluate the structure of the non-woven scaf-
folds. 
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APPENDIX 1: WELL PLATE IMAGES OF COMP50 SCAFFOLDS 
 
 
 
Light microscopy images of the well plates at a time point of 3 days. Scale bars 1.0 mm. 
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APPENDIX 2: LIVE/DEAD EXPERIMENTS 1 & 2 (1/2) 
 
COMP50 Experiment 1 - scale bars 500 µm. 
 
 
COMP50 Experiment 2 - scale bars 500 µm. 
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APPENDIX 2: LIVE/DEAD EXPERIMENTS 1 & 2 (2/2) 
 
 
PLCL experiment 1 – scale bars 500 µm. 
 
 
PLCL experiment 2 – scale bars 500 µm. 
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APPENDIX 3: PLCL & COMP50 CYQUANT RESULTS (1/2) 
 
 
Parallel relative PLCL & COMP50 CyQUANT results. 
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APPENDIX 3: PLCL & COMP50 CYQUANT RESULTS (2/2) 
 
Parallel absolute PLCL & COMP50 CyQUANT results. 
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APPENDIX 4: PLCL MICRO-CT EXPERIMENTS 1 & 2 
 
Sc-PLCL - Micro-CT Experiment 1. The statically seeded scaffold was individually im-
aged. The piles show the scaffold material being stepwise faded away. On the right, only 
signals from the USPIO particles are seen. 
 
 
Sc-PLCL - Micro-CT Experiment 2. Again, the piles represent the same scaffolds with a 
different type of image processing: on the left, only the scaffold is seen. On the right, only 
USPIO particle signals are shown. Scale bar 5.0 mm. 
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APPENDIX 5: PRUSSIAN BLUE RESULTS 
 
Prussian blue staining results. Each row shows four images from different sites of the 
same sample. Scale bar 50 µm. 
